supplied by www.ccc.ac.at

279 Einträge

Activity of T-DM1 in Her2-positive breast cancer brain metastases.
Autoren Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Dubsky P, Dieckmann K, Pinker K, Bago-Horvath Z, Galid A, Oehler L, Zielinski CC, Gnant M, Steger GG, Preusser M
Erscheinungsdaten Clinical & experimental metastasis. 2015 Aug 25. doi: 10.1007/s10585-015-9740-3
Publikations ID PMID: 26303828
 


Development and verification of the PAM50-based Prosigna breast cancer gene signature assay.
Autoren Wallden B, Storhoff J, Nielsen T, Dowidar N, Schaper C, Ferree S, Liu S, Leung S, Geiss G, Snider J, Vickery T, Davies SR, Mardis ER, Gnant M, Sestak I, Ellis MJ, Perou CM, Bernard PS, Parker JS
Erscheinungsdaten BMC medical genomics. 2015 Aug 22. doi: 10.1186/s12920-015-0129-6. pii: 10.1186/s12920-015-0129-6. pmc: PMC4546262
Publikations ID PMID: 26297356
 


Bevacizumab: no comeback in early breast cancer?
Autoren Bartsch R, Gnant M, Steger GG
Erscheinungsdaten The Lancet. Oncology. 2015 Aug 10. pii: S1470-2045(15)00124-2. doi: 10.1016/S1470-2045(15)00124-2
Publikations ID PMID: 26272771
 


Targeting bone microenvironment: Clinical implications.
Autoren Gnant M
Erscheinungsdaten Breast (Edinburgh, Scotland). 2015 Jul 31. pii: S0960-9776(15)00150-2. doi: 10.1016/j.breast.2015.07.012
Publikations ID PMID: 26238438
 


St. Gallen/Vienna 2015: A Brief Summary of the Consensus Discussion.
Autoren Gnant M, Thomssen C, Harbeck N
Erscheinungsdaten Breast care (Basel, Switzerland). 2015 Jul 21. doi: 10.1159/000430488. pii: brc-0010-0124. pmc: PMC4464099
Publikations ID PMID: 26195941
 


Postoperative CMF Does Not Ameliorate Poor Outcomes in Women With Residual Invasive Breast Cancer After Neoadjuvant Epirubicin/Docetaxel Chemotherapy.
Autoren Promberger R, Dubsky P, Mittlböck M, Ott J, Singer C, Seemann R, Exner R, Panhofer P, Steger G, Bergen E, Gnant M, Jakesz R, Bago-Horvath Z, Rudas M, Bartsch R
Erscheinungsdaten Clinical breast cancer. 2015 Jun 18. pii: S1526-8209(15)00123-8. doi: 10.1016/j.clbc.2015.06.007
Publikations ID PMID: 26195436
 


Final 10-year results of the Breast International Group 2-98 phase III trial and the role of Ki67 in predicting benefit of adjuvant docetaxel in patients with oestrogen receptor positive breast cancer.
Autoren Sonnenblick A, Francis PA, Azim HA, de Azambuja E, Nordenskjöld B, Gutiérez J, Quinaux E, Mastropasqua MG, Ameye L, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Barnadas A, Cortes-Funes H, Piccart M, Crown J
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2015 Jun 11. pii: S0959-8049(15)00285-3. doi: 10.1016/j.ejca.2015.03.018
Publikations ID PMID: 26074397
 


Adjuvant denosumab in breast cancer (ABCSG-18): a multicentre, randomised, double-blind, placebo-controlled trial.
Autoren Gnant M, Pfeiler G, Dubsky PC, Hubalek M, Greil R, Jakesz R, Wette V, Balic M, Haslbauer F, Melbinger E, Bjelic-Radisic V, Artner-Matuschek S, Fitzal F, Marth C, Sevelda P, Mlineritsch B, Steger GG, Manfreda D, Exner R, Egle D, Bergh J, Kainberger F, Talbot S, Warner D, Fesl C, Singer CF
Erscheinungsdaten Lancet (London, England). 2015 May 31. pii: S0140-6736(15)60995-3. doi: 10.1016/S0140-6736(15)60995-3
Publikations ID PMID: 26040499
 


Tailoring therapies-improving the management of early breast cancer: St Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2015.
Autoren Coates AS, Winer EP, Goldhirsch A, Gelber RD, Gnant M, Piccart-Gebhart M, Thürlimann B, Senn HJ
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 4. pii: mdv221. doi: 10.1093/annonc/mdv221. pmc: PMC4511219
Publikations ID PMID: 25939896
 


Reply to the letter to the editor 'Duration of endocrine therapy and its impact on the results of adjuvant trials in premenopausal breast cancer patients' by Fouad et al.
Autoren Gnant M, Dubsky PC
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 4. pii: mdv218. doi: 10.1093/annonc/mdv218
Publikations ID PMID: 25939895
 


Identifying clinically relevant prognostic subgroups of postmenopausal women with node-positive hormone receptor-positive early-stage breast cancer treated with endocrine therapy: a combined analysis of ABCSG-8 and ATAC using the PAM50 risk of recurrence score and intrinsic subtype.
Autoren Gnant M, Sestak I, Filipits M, Dowsett M, Balic M, Lopez-Knowles E, Greil R, Dubsky P, Stoeger H, Rudas M, Jakesz R, Ferree S, Cowens JW, Nielsen T, Schaper C, Fesl C, Cuzick J
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 May 1. pii: mdv215. doi: 10.1093/annonc/mdv215
Publikations ID PMID: 25935792
 


The genomic expression test EndoPredict is a prognostic tool for identifying risk of local recurrence in postmenopausal endocrine receptor-positive, her2neu-negative breast cancer patients randomised within the prospective ABCSG 8 trial.
Autoren Fitzal F, Filipits M, Rudas M, Greil R, Dietze O, Samonigg H, Lax S, Herz W, Dubsky P, Bartsch R, Kronenwett R, Gnant M
Erscheinungsdaten British journal of cancer. 2015 Mar 24. pii: bjc201598. doi: 10.1038/bjc.2015.98. pmc: PMC4402462
Publikations ID PMID: 25867274
 


Taxanes Plus Trastuzumab Compared To Oral Vinorelbine Plus Trastuzumab in HER2-Overexpressing Metastatic Breast Cancer.
Autoren Bergen E, Berghoff AS, Rudas M, Dubsky P, De Vries C, Sattlberger C, Mader RM, Zagouri F, Sparber C, Fitzal F, Gnant M, Rottenfusser A, Zielinski CC, Preusser M, Steger GG, Bartsch R
Erscheinungsdaten Breast care (Basel, Switzerland). 2015 Mar 11. doi: 10.1159/000368330. pii: brc-0009-0344. pmc: PMC4322687
Publikations ID PMID: 25759615
 


CDK4/6 inhibitors in luminal breast cancer.
Autoren Gnant M, Steger GG, Bartsch R
Erscheinungsdaten The Lancet. Oncology. 2014 Dec 16. pii: S1470-2045(14)71188-X. doi: 10.1016/S1470-2045(14)71188-X
Publikations ID PMID: 25524801
 


Zoledronic acid combined with adjuvant endocrine therapy of tamoxifen versus anastrozol plus ovarian function suppression in premenopausal early breast cancer: final analysis of the Austrian Breast and Colorectal Cancer Study Group Trial 12.
Autoren Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Knauer M, Moik M, Jakesz R, Seifert M, Taucher S, Bjelic-Radisic V, Balic M, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Selim U, Fitzal F, Hochreiner G, Wette V, Sevelda P, Ploner F, Bartsch R, Fesl C, Greil R
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Nov 17. pii: mdu544. doi: 10.1093/annonc/mdu544
Publikations ID PMID: 25403582
 


Preoperative treatment with capecitabine, cetuximab and radiotherapy for primary locally advanced rectal cancer--a phase II clinical trial.
Autoren Eisterer W, De Vries A, Öfner D, Rabl H, Koplmüller R, Greil R, Tschmelitsch J, Schmid R, Kapp K, Lukas P, Sedlmayer F, Höfler G, Gnant M, Thaler J
Erscheinungsdaten Anticancer research. 2014 Nov 4. pii: 34/11/6767
Publikations ID PMID: 25368289
 


Prediction of late distant recurrence after 5 years of endocrine treatment: a combined analysis of patients from the Austrian breast and colorectal cancer study group 8 and arimidex, tamoxifen alone or in combination randomized trials using the PAM50 risk of recurrence score.
Autoren Sestak I, Cuzick J, Dowsett M, Lopez-Knowles E, Filipits M, Dubsky P, Cowens JW, Ferree S, Schaper C, Fesl C, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2014 Oct 20. pii: JCO.2014.55.6894. doi: 10.1200/JCO.2014.55.6894
Publikations ID PMID: 25332252
 


Everolimus plus exemestane for hormone-receptor-positive, human epidermal growth factor receptor-2-negative advanced breast cancer: overall survival results from BOLERO-2†.
Autoren Piccart M, Hortobagyi GN, Campone M, Pritchard KI, Lebrun F, Ito Y, Noguchi S, Perez A, Rugo HS, Deleu I, Burris HA, Provencher L, Neven P, Gnant M, Shtivelband M, Wu C, Fan J, Feng W, Taran T, Baselga J
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2014 Sep 17. pii: mdu456. doi: 10.1093/annonc/mdu456
Publikations ID PMID: 25231953
 


Co-overexpression of HER2/HER3 is a predictor of impaired survival in breast cancer patients.
Autoren Berghoff AS, Bartsch R, Preusser M, Ricken G, Steger GG, Bago-Horvath Z, Rudas M, Streubel B, Dubsky P, Gnant M, Fitzal F, Zielinski CC, Birner P
Erscheinungsdaten Breast (Edinburgh, Scotland). 2014 Jul 10. pii: S0960-9776(14)00124-6. doi: 10.1016/j.breast.2014.06.011
Publikations ID PMID: 25017122
 


The multigene signature MammaPrint impacts on multidisciplinary team decisions in ER+, HER2- early breast cancer.
Autoren Exner R, Bago-Horvath Z, Bartsch R, Mittlboeck M, Retèl VP, Fitzal F, Rudas M, Singer C, Pfeiler G, Gnant M, Jakesz R, Dubsky P
Erscheinungsdaten British journal of cancer. 2014 Jul 8. pii: bjc2014339. doi: 10.1038/bjc.2014.339. pmc: PMC4150264
Publikations ID PMID: 25003667
 


HER2-positive breast cancer: a new piece of the puzzle.
Autoren Gnant M, Bartsch R, Steger GG
Erscheinungsdaten The Lancet. Oncology. 2014 May 2. pii: S1470-2045(14)70192-5. doi: 10.1016/S1470-2045(14)70192-5
Publikations ID PMID: 24793817
 


A phase II trial of two durations of Bevacizumab added to neoadjuvant gemcitabine for borderline and locally advanced pancreatic cancer.
Autoren Sahora K, Schindl M, Kuehrer I, Eisenhut A, Werba G, Brostjan C, Telek B, Ba'ssalamah A, Stift J, Schoppmann SF, Gnant M
Erscheinungsdaten Anticancer research. 2014 Apr 29. pii: 34/5/2377
Publikations ID PMID: 24778046
 


The impact of educational materials on compliance and persistence rates with adjuvant aromatase inhibitor treatment: first-year results from the compliance of aromatase inhibitors assessment in daily practice through educational approach (CARIATIDE) study.
Autoren Neven P, Markopoulos C, Tanner M, Marty M, Kreienberg R, Atkins L, Franquet A, Gnant M, Neciosup S, Tesarova P, Barni S, Deschamp V
Erscheinungsdaten Breast (Edinburgh, Scotland). 2014 Mar 24. pii: S0960-9776(14)00039-3. doi: 10.1016/j.breast.2014.02.009
Publikations ID PMID: 24675394
 


Follow-up after breast cancer diagnosis.
Autoren Thomssen C, Diel I, Gnant M, Goldmann-Posch U, Göschke C, Haidinger R, Janni W, Lin NU
Erscheinungsdaten Breast care (Basel, Switzerland). 2014 Feb 19. doi: 10.1159/000357586. pii: brc-0008-0457. pmc: PMC3919482
Publikations ID PMID: 24550757
 


The PAM50 risk-of-recurrence score predicts risk for late distant recurrence after endocrine therapy in postmenopausal women with endocrine-responsive early breast cancer.
Autoren Filipits M, Nielsen TO, Rudas M, Greil R, Stöger H, Jakesz R, Bago-Horvath Z, Dietze O, Regitnig P, Gruber-Rossipal C, Müller-Holzner E, Singer CF, Mlineritsch B, Dubsky P, Bauernhofer T, Hubalek M, Knauer M, Trapl H, Fesl C, Schaper C, Ferree S, Liu S, Cowens JW, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2014 Feb 11. pii: 1078-0432.CCR-13-1845. doi: 10.1158/1078-0432.CCR-13-1845
Publikations ID PMID: 24520097
 


Standardization of morbidity assessment in breast cancer surgery using the Clavien Dindo Classification.
Autoren Panhofer P, Ferenc V, Schütz M, Gleiss A, Dubsky P, Jakesz R, Gnant M, Fitzal F
Erscheinungsdaten International journal of surgery (London, England). 2014 Jan 31. pii: S1743-9191(14)00020-X. doi: 10.1016/j.ijsu.2014.01.012
Publikations ID PMID: 24486930
 


Guidelines: usefulness and limitations.
Autoren Gnant M
Erscheinungsdaten Breast care (Basel, Switzerland). 2014 Jan 13. doi: 10.1159/000353791. pii: brc-0008-0172. pmc: PMC3728632
Publikations ID PMID: 24415965
 


Epirubicin and docetaxel with or without capecitabine as neoadjuvant treatment for early breast cancer: final results of a randomized phase III study (ABCSG-24).
Autoren Steger GG, Greil R, Lang A, Rudas M, Fitzal F, Mlineritsch B, Hartmann BL, Bartsch R, Melbinger E, Hubalek M, Stoeger H, Dubsky P, Ressler S, Petzer AL, Singer CF, Muss C, Jakesz R, Gampenrieder SP, Zielinski CC, Fesl C, Gnant M
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt508. doi: 10.1093/annonc/mdt508
Publikations ID PMID: 24347519
 


Predicting distant recurrence in receptor-positive breast cancer patients with limited clinicopathological risk: using the PAM50 Risk of Recurrence score in 1478 postmenopausal patients of the ABCSG-8 trial treated with adjuvant endocrine therapy alone.
Autoren Gnant M, Filipits M, Greil R, Stoeger H, Rudas M, Bago-Horvath Z, Mlineritsch B, Kwasny W, Knauer M, Singer C, Jakesz R, Dubsky P, Fitzal F, Bartsch R, Steger G, Balic M, Ressler S, Cowens JW, Storhoff J, Ferree S, Schaper C, Liu S, Fesl C, Nielsen TO
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2013 Dec 16. pii: mdt494. doi: 10.1093/annonc/mdt494
Publikations ID PMID: 24347518
 


Differential survival trends of stage II colorectal cancer patients relate to promoter methylation status of PCDH10, SPARC, and UCHL1.
Autoren Heitzer E, Artl M, Filipits M, Resel M, Graf R, Weißenbacher B, Lax S, Gnant M, Wrba F, Greil R, Dietze O, Hofbauer F, Böhm G, Höfler G, Samonigg H, Schaberl-Moser R, Balic M, Dandachi N
Erscheinungsdaten Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc. 2013 Dec 6. pii: modpathol2013204. doi: 10.1038/modpathol.2013.204
Publikations ID PMID: 24309322
 


The EndoPredict score provides prognostic information on late distant metastases in ER+/HER2- breast cancer patients.
Autoren Dubsky P, Brase JC, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Fisch K, Kronenwett R, Gnant M, Filipits M
Erscheinungsdaten British journal of cancer. 2013 Oct 24. pii: bjc2013671. doi: 10.1038/bjc.2013.671. pmc: PMC3859949
Publikations ID PMID: 24157828
 


Impact of body mass index on estradiol depletion by aromatase inhibitors in postmenopausal women with early breast cancer.
Autoren Pfeiler G, Königsberg R, Hadji P, Fitzal F, Maroske M, Dressel-Ban G, Zellinger J, Exner R, Seifert M, Singer C, Gnant M, Dubsky P
Erscheinungsdaten British journal of cancer. 2013 Sep 3. pii: bjc2013499. doi: 10.1038/bjc.2013.499. pmc: PMC3777005
Publikations ID PMID: 24002592
 


Role of bisphosphonates in postmenopausal women with breast cancer.
Autoren Gnant M
Erscheinungsdaten Cancer treatment reviews. 2013 Jul 29. pii: S0305-7372(13)00134-5. doi: 10.1016/j.ctrv.2013.07.003
Publikations ID PMID: 23906846
 


The predictive impact of body mass index on the efficacy of extended adjuvant endocrine treatment with anastrozole in postmenopausal patients with breast cancer: an analysis of the randomised ABCSG-6a trial.
Autoren Gnant M, Pfeiler G, Stöger H, Mlineritsch B, Fitzal F, Balic M, Kwasny W, Seifert M, Stierer M, Dubsky P, Greil R, Steger G, Samonigg H, Fesl C, Jakesz R
Erscheinungsdaten British journal of cancer. 2013 Jul 18. pii: bjc2013367. doi: 10.1038/bjc.2013.367. pmc: PMC3738117
Publikations ID PMID: 23868011
 


Aromatase inhibitors with or without gonadotropin-releasing hormone analogue in metastatic male breast cancer: a case series.
Autoren Zagouri F, Sergentanis TN, Koutoulidis V, Sparber C, Steger GG, Dubsky P, Zografos GC, Psaltopoulou T, Gnant M, Dimopoulos MA, Bartsch R
Erscheinungsdaten British journal of cancer. 2013 May 30. pii: bjc2013255. doi: 10.1038/bjc.2013.255. pmc: PMC3681005
Publikations ID PMID: 23722469
 


Efficacy of tamoxifen ± aminoglutethimide in normal weight and overweight postmenopausal patients with hormone receptor-positive breast cancer: an analysis of 1509 patients of the ABCSG-06 trial.
Autoren Pfeiler G, Stöger H, Dubsky P, Mlineritsch B, Singer C, Balic M, Fitzal F, Moik M, Kwasny W, Selim U, Renner K, Ploner F, Steger GG, Seifert M, Hofbauer F, Sandbichler P, Samonigg H, Jakesz R, Greil R, Fesl C, Gnant M
Erscheinungsdaten British journal of cancer. 2013 Mar 19. pii: bjc2013114. doi: 10.1038/bjc.2013.114. pmc: PMC3629426
Publikations ID PMID: 23511562
 


Effect of everolimus on bone marker levels and progressive disease in bone in BOLERO-2.
Autoren Gnant M, Baselga J, Rugo HS, Noguchi S, Burris HA, Piccart M, Hortobagyi GN, Eakle J, Mukai H, Iwata H, Geberth M, Hart LL, Hadji P, El-Hashimy M, Rao S, Taran T, Sahmoud T, Lebwohl D, Campone M, Pritchard KI
Erscheinungsdaten Journal of the National Cancer Institute. 2013 Feb 19. pii: djt026. doi: 10.1093/jnci/djt026
Publikations ID PMID: 23425564
 


Plasma HMGB-1 after the initial dose of epirubicin/docetaxel in cancer.
Autoren Arnold T, Michlmayr A, Baumann S, Burghuber C, Pluschnig U, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R
Erscheinungsdaten European journal of clinical investigation. 2013 Jan 25. doi: 10.1111/eci.12043
Publikations ID PMID: 23410002
 


Impact of HER-2-targeted therapy on overall survival in patients with HER-2 positive metastatic breast cancer.
Autoren Berghoff AS, Bago-Horvath Z, Dubsky P, Rudas M, Pluschnig U, Wiltschke C, Gnant M, Steger GG, Zielinski CC, Bartsch R
Erscheinungsdaten The breast journal. 2013 Jan 27. doi: 10.1111/tbj.12070
Publikations ID PMID: 23350584
 


Overcoming endocrine resistance in breast cancer: importance of mTOR inhibition.
Autoren Gnant M
Erscheinungsdaten Expert review of anticancer therapy. 2012 Dec 20. doi: 10.1586/era.12.138
Publikations ID PMID: 23253223
 


The role of mammalian target of rapamycin (mTOR) inhibition in the treatment of advanced breast cancer.
Autoren Gnant M
Erscheinungsdaten Current oncology reports. 2013 Jan 7. doi: 10.1007/s11912-012-0277-1
Publikations ID PMID: 23054937
 


Adjuvant bisphosphonates: a new standard of care?
Autoren Gnant M
Erscheinungsdaten Current opinion in oncology. 2012 Oct 19. doi: 10.1097/CCO.0b013e32835771aa
Publikations ID PMID: 23042123
 


EndoPredict improves the prognostic classification derived from common clinical guidelines in ER-positive, HER2-negative early breast cancer.
Autoren Dubsky P, Filipits M, Jakesz R, Rudas M, Singer CF, Greil R, Dietze O, Luisser I, Klug E, Sedivy R, Bachner M, Mayr D, Schmidt M, Gehrmann MC, Petry C, Weber KE, Kronenwett R, Brase JC, Gnant M
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2012 Oct 3. pii: mds334. doi: 10.1093/annonc/mds334. pmc: PMC3574544
Publikations ID PMID: 23035151
 


8th European Breast Cancer Conference (EBCC-8), Vienna, March 21-24, 2012.
Autoren Gnant M, Beermann B
Erscheinungsdaten Breast care (Basel, Switzerland). 2012 Jun 28. doi: 10.1159/000188070. pii: brc-0007-0170. pmc: PMC3376360
Publikations ID PMID: 22740806
 


Treatment of Bone Metastases in Patients with Advanced Breast Cancer.
Autoren Gnant M, Balic M, Petru E, Raunik W, Singer CF, Steger GG, Watzke IM, Brodowicz T
Erscheinungsdaten Breast care (Basel, Switzerland). 2012 Apr 24. doi: 10.1159/000338650. pii: brc-0007-0092. pmc: PMC3376361
Publikations ID PMID: 22740794
 


Axillary Dissection in the Case of Positive Sentinel Lymph Nodes: Results of the Innsbruck Consensus Conference.
Autoren Hubalek M, Bartsch R, Gnant M, Kapp KS, Lang A, Lax S, Lukas P, Neunteufel W, Pristauz G, Reitsamer R, Sandbichler P, Schrenk P, Singer C, Tamussino K, Tschmelitsch J, Zeimet AG, Marth C
Erscheinungsdaten Geburtshilfe und Frauenheilkunde. 2014 Oct 6. doi: 10.1055/s-0031-1298441. pmc: PMC4168401
Publikations ID PMID: 25284834
 


Ovarian function suppression and fulvestrant as endocrine therapy in premenopausal women with metastatic breast cancer.
Autoren Bartsch R, Bago-Horvath Z, Berghoff A, DeVries C, Pluschnig U, Dubsky P, Rudas M, Mader RM, Rottenfusser A, Fitzal F, Gnant M, Zielinski CC, Steger GG
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2012 Mar 27. pii: S0959-8049(12)00247-X. doi: 10.1016/j.ejca.2012.03.002
Publikations ID PMID: 22459763
 


Podoplanin-expressing cancer-associated fibroblasts are associated with poor prognosis in invasive breast cancer.
Autoren Schoppmann SF, Berghoff A, Dinhof C, Jakesz R, Gnant M, Dubsky P, Jesch B, Heinzl H, Birner P
Erscheinungsdaten Breast cancer research and treatment. 2012 Feb 17. doi: 10.1007/s10549-012-1984-x
Publikations ID PMID: 22350732
 


Bisphosphonates: prevention of bone metastases in breast cancer.
Autoren Gnant M, Dubsky P, Hadji P
Erscheinungsdaten Recent results in cancer research. Fortschritte der Krebsforschung. Progrès dans les recherches sur le cancer. 2012 Feb 6. doi: 10.1007/978-3-642-21892-7_3
Publikations ID PMID: 22307370
 


Tamoxifen and anastrozole as a sequencing strategy: a randomized controlled trial in postmenopausal patients with endocrine-responsive early breast cancer from the Austrian Breast and Colorectal Cancer Study Group.
Autoren Dubsky PC, Jakesz R, Mlineritsch B, Pöstlberger S, Samonigg H, Kwasny W, Tausch C, Stöger H, Haider K, Fitzal F, Singer CF, Stierer M, Sevelda P, Luschin-Ebengreuth G, Taucher S, Rudas M, Bartsch R, Steger GG, Greil R, Filipcic L, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2012 Jan 23. pii: JCO.2011.36.8993. doi: 10.1200/JCO.2011.36.8993
Publikations ID PMID: 22271481
 


Dual inhibition of HER2 in breast cancer treatment.
Autoren Gnant M, Steger GG
Erscheinungsdaten Lancet (London, England). 2012 Jan 17. pii: S0140-6736(12)60068-3. doi: 10.1016/S0140-6736(12)60068-3
Publikations ID PMID: 22257672
 


Brain metastases free survival differs between breast cancer subtypes.
Autoren Berghoff A, Bago-Horvath Z, De Vries C, Dubsky P, Pluschnig U, Rudas M, Rottenfusser A, Knauer M, Eiter H, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R
Erscheinungsdaten British journal of cancer. 2012 Jan 10. pii: bjc2011597. doi: 10.1038/bjc.2011.597. pmc: PMC3273356
Publikations ID PMID: 22233926
 


Objectively measured breast symmetry has no influence on quality of life in breast cancer patients.
Autoren Exner R, Krois W, Mittlböck M, Dubsky P, Jakesz R, Gnant M, Fitzal F
Erscheinungsdaten European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2011 Dec 5. pii: S0748-7983(11)00655-X. doi: 10.1016/j.ejso.2011.10.012
Publikations ID PMID: 22152943
 


Intravenous bisphosphonates for breast cancer: impact on patient outcomes and scientific concepts.
Autoren Gnant M
Erscheinungsdaten Breast disease. 2012 Mar 5. pii: M18P845061116725. doi: 10.3233/BD-2010-0325
Publikations ID PMID: 22142663
 


Impact of anti-HER2 therapy on overall survival in HER2-overexpressing breast cancer patients with brain metastases.
Autoren Bartsch R, Berghoff A, Pluschnig U, Bago-Horvath Z, Dubsky P, Rottenfusser A, DeVries C, Rudas M, Fitzal F, Dieckmann K, Mader RM, Gnant M, Zielinski CC, Steger GG
Erscheinungsdaten British journal of cancer. 2011 Nov 29. pii: bjc2011531. doi: 10.1038/bjc.2011.531. pmc: PMC3251869
Publikations ID PMID: 22127284
 


Zoledronic acid in the treatment of early-stage breast cancer: is there a final verdict?
Autoren Gnant M
Erscheinungsdaten Current oncology reports. 2012 Jan 25. doi: 10.1007/s11912-011-0209-5
Publikations ID PMID: 22113793
 


Zoledronic acid in breast cancer: latest findings and interpretations.
Autoren Gnant M
Erscheinungsdaten Therapeutic advances in medical oncology. 2011 Nov 15. doi: 10.1177/1758834011420599. pii: 10.1177_1758834011420599. pmc: PMC3210470
Publikations ID PMID: 22084643
 


Targeted therapies: adjuvant bisphosphonates--an option with low estrogen?
Autoren Gnant M
Erscheinungsdaten Nature reviews. Clinical oncology. 2011 Nov 8. pii: nrclinonc.2011.170. doi: 10.1038/nrclinonc.2011.170
Publikations ID PMID: 22064460
 


Discrimination between circulating endothelial cells and blood cell populations with overlapping phenotype reveals distinct regulation and predictive potential in cancer therapy.
Autoren Starlinger P, Brugger P, Reiter C, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C
Erscheinungsdaten Neoplasia (New York, N.Y.). 2011 Oct 26. pmc: PMC3201574
Publikations ID PMID: 22028623
 


Adjuvant sequencing of tamoxifen and anastrozole is superior to tamoxifen alone in postmenopausal women with low proliferating breast cancer.
Autoren Bago-Horvath Z, Rudas M, Dubsky P, Jakesz R, Singer CF, Kemmerling R, Greil R, Jelen A, Böhm G, Jasarevic Z, Haid A, Gruber C, Pöstlberger S, Filipits M, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Oct 13. pii: 1078-0432.CCR-11-1846. doi: 10.1158/1078-0432.CCR-11-1846
Publikations ID PMID: 21998336
 


Direct and indirect anticancer activity of bisphosphonates: a brief review of published literature.
Autoren Gnant M, Clézardin P
Erscheinungsdaten Cancer treatment reviews. 2011 Oct 7. pii: S0305-7372(11)00199-X. doi: 10.1016/j.ctrv.2011.09.003
Publikations ID PMID: 21983264
 


Platelet-stored angiogenesis factors: clinical monitoring is prone to artifacts.
Autoren Starlinger P, Alidzanovic L, Schauer D, Brugger P, Sommerfeldt S, Kuehrer I, Schoppmann SF, Gnant M, Brostjan C
Erscheinungsdaten Disease markers. 2011 Sep 7. pii: B774V8K517541720. doi: 10.3233/DMA-2011-0798. pmc: PMC3826483
Publikations ID PMID: 21896999
 


Anticancer activity of bisphosphonates in breast cancer.
Autoren Gnant M
Erscheinungsdaten Anti-cancer agents in medicinal chemistry. 2012 Feb 14. pii: BSP/ACAMC/E-Pub/ 00232
Publikations ID PMID: 21864231
 


A new molecular predictor of distant recurrence in ER-positive, HER2-negative breast cancer adds independent information to conventional clinical risk factors.
Autoren Filipits M, Rudas M, Jakesz R, Dubsky P, Fitzal F, Singer CF, Dietze O, Greil R, Jelen A, Sevelda P, Freibauer C, Müller V, Jänicke F, Schmidt M, Kölbl H, Rody A, Kaufmann M, Schroth W, Brauch H, Schwab M, Fritz P, Weber KE, Feder IS, Hennig G, Kronenwett R, Gehrmann M, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2011 Aug 1. pii: 1078-0432.CCR-11-0926. doi: 10.1158/1078-0432.CCR-11-0926
Publikations ID PMID: 21807638
 


Neoadjuvant chemotherapy increases the rate of breast conservation in lobular-type breast cancer patients.
Autoren Fitzal F, Mittlboeck M, Steger G, Bartsch R, Rudas M, Dubsky P, Riedl O, Jakesz R, Gnant M
Erscheinungsdaten Annals of surgical oncology. 2011 Jul 9. doi: 10.1245/s10434-011-1879-9
Publikations ID PMID: 21743980
 


Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 62-month follow-up from the ABCSG-12 randomised trial.
Autoren Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Heck D, Menzel C, Jakesz R, Seifert M, Hubalek M, Pristauz G, Bauernhofer T, Eidtmann H, Eiermann W, Steger G, Kwasny W, Dubsky P, Hochreiner G, Forsthuber EP, Fesl C, Greil R
Erscheinungsdaten The Lancet. Oncology. 2011 Jun 5. pii: S1470-2045(11)70122-X. doi: 10.1016/S1470-2045(11)70122-X
Publikations ID PMID: 21641868
 


Impact of body mass index on the efficacy of endocrine therapy in premenopausal patients with breast cancer: an analysis of the prospective ABCSG-12 trial.
Autoren Pfeiler G, Königsberg R, Fesl C, Mlineritsch B, Stoeger H, Singer CF, Pöstlberger S, Steger GG, Seifert M, Dubsky P, Taucher S, Samonigg H, Bjelic-Radisic V, Greil R, Marth C, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 May 9. pii: JCO.2010.33.2585. doi: 10.1200/JCO.2010.33.2585
Publikations ID PMID: 21555684
 


Lipoxygenase mediates invasion of intrametastatic lymphatic vessels and propagates lymph node metastasis of human mammary carcinoma xenografts in mouse.
Autoren Kerjaschki D, Bago-Horvath Z, Rudas M, Sexl V, Schneckenleithner C, Wolbank S, Bartel G, Krieger S, Kalt R, Hantusch B, Keller T, Nagy-Bojarszky K, Huttary N, Raab I, Lackner K, Krautgasser K, Schachner H, Kaserer K, Rezar S, Madlener S, Vonach C, Davidovits A, Nosaka H, Hämmerle M, Viola K, Dolznig H, Schreiber M, Nader A, Mikulits W, Gnant M, Hirakawa S, Detmar M, Alitalo K, Nijman S, Offner F, Maier TJ, Steinhilber D, Krupitza G
Erscheinungsdaten The Journal of clinical investigation. 2011 Apr 11. pii: 44751. doi: 10.1172/JCI44751. pmc: PMC3083794
Publikations ID PMID: 21540548
 


NeoGemTax: gemcitabine and docetaxel as neoadjuvant treatment for locally advanced nonmetastasized pancreatic cancer.
Autoren Sahora K, Kuehrer I, Schindl M, Koelblinger C, Goetzinger P, Gnant M
Erscheinungsdaten World journal of surgery. 2011 Jul 22. doi: 10.1007/s00268-011-1113-8
Publikations ID PMID: 21523499
 


Prevention of bone metastases and management of bone health in early breast cancer.
Autoren Gnant M, Hadji P
Erscheinungsdaten Breast cancer research : BCR. 2010 Dec 17. pii: bcr2768. doi: 10.1186/bcr2768. pmc: PMC3046430
Publikations ID PMID: 21172067
 


The evolution of bone-targeted therapies: introduction.
Autoren Gnant M
Erscheinungsdaten Seminars in oncology. 2010 Nov 29. pii: S0093-7754(10)00173-9. doi: 10.1053/j.seminoncol.2010.10.003
Publikations ID PMID: 21111243
 


Modulation of plasma complement by the initial dose of epirubicin/docetaxel therapy in breast cancer and its predictive value.
Autoren Michlmayr A, Bachleitner-Hofmann T, Baumann S, Marchetti-Deschmann M, Rech-Weichselbraun I, Burghuber C, Pluschnig U, Bartsch R, Graf A, Greil R, Allmaier G, Steger G, Gnant M, Bergmann M, Oehler R
Erscheinungsdaten British journal of cancer. 2010 Sep 28. pii: 6605909. doi: 10.1038/sj.bjc.6605909. pmc: PMC2967072
Publikations ID PMID: 20877360
 


Oncologic safety of breast conserving surgery after tumour downsizing by neoadjuvant therapy: a retrospective single centre cohort study.
Autoren Fitzal F, Riedl O, Mittlböck M, Dubsky P, Bartsch R, Steger G, Jakesz R, Gnant M
Erscheinungsdaten Breast cancer research and treatment. 2010 Sep 17. doi: 10.1007/s10549-010-1164-9
Publikations ID PMID: 20848185
 


NeoGemOx: Gemcitabine and oxaliplatin as neoadjuvant treatment for locally advanced, nonmetastasized pancreatic cancer.
Autoren Sahora K, Kuehrer I, Eisenhut A, Akan B, Koellblinger C, Goetzinger P, Teleky B, Jakesz R, Peck-Radosavljevic M, Ba'ssalamah A, Zielinski C, Gnant M
Erscheinungsdaten Surgery. 2010 Sep 6. pii: S0039-6060(10)00416-2. doi: 10.1016/j.surg.2010.07.048
Publikations ID PMID: 20817204
 


The anti-tumor effect of bisphosphonates ABCSG-12, ZO-FAST and more ...
Autoren Gnant M, Eidtmann H
Erscheinungsdaten Critical reviews in oncology/hematology. 2010 Apr 29. pii: S1040-8428(10)70003-2. doi: 10.1016/S1040-8428(10)70003-2
Publikations ID PMID: 20427029
 


Bisphosphonates in the prevention of disease recurrence: current results and ongoing trials.
Autoren Gnant M
Erscheinungsdaten Current cancer drug targets. 2009 Dec 22.
Publikations ID PMID: 20025570
 


Fighting overtreatment in adjuvant breast cancer therapy.
Autoren Gnant M, Steger GG
Erscheinungsdaten Lancet (London, England). 2009 Dec 10. pii: S0140-6736(09)62097-3. doi: 10.1016/S0140-6736(09)62097-3
Publikations ID PMID: 20004965
 


HER2/neu expression correlates with vascular endothelial growth factor-C and lymphangiogenesis in lymph node-positive breast cancer.
Autoren Schoppmann SF, Tamandl D, Roberts L, Jomrich G, Schoppmann A, Zwrtek R, Dubsky P, Gnant M, Jakesz R, Birner P
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2009 Nov 25. pii: mdp532. doi: 10.1093/annonc/mdp532
Publikations ID PMID: 19940005
 


Adjuvant bisphosphonates in endocrine-responsive breast cancer: what is their place in therapy?
Autoren Gnant M, Blaha P, Dubsky P, Exner R, Fitzal F, Sporn E, Panhofer P, Borgo AD, Bigenzahn S, Steger G, Jakesz R
Erscheinungsdaten Therapeutic advances in medical oncology. 2011 Jul 26. doi: 10.1177/1758834009344594. pii: 10.1177_1758834009344594. pmc: PMC3126000
Publikations ID PMID: 21789117
 


Predicting for activity of second-line trastuzumab-based therapy in her2-positive advanced breast cancer.
Autoren Bartsch R, De Vries C, Pluschnig U, Dubsky P, Bago-Horvath Z, Gampenrieder SP, Rudas M, Mader RM, Rottenfusser A, Wiltschke C, Gnant M, Zielinski CC, Steger GG
Erscheinungsdaten BMC cancer. 2009 Oct 17. pii: 1471-2407-9-367. doi: 10.1186/1471-2407-9-367. pmc: PMC2770076
Publikations ID PMID: 19835621
 


Low p27 expression predicts early relapse and death in postmenopausal hormone receptor-positive breast cancer patients receiving adjuvant tamoxifen therapy.
Autoren Filipits M, Rudas M, Heinzl H, Jakesz R, Kubista E, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Nader A, Stierer M, Gnant MF
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2009 Sep 1. pii: 1078-0432.CCR-09-0728. doi: 10.1158/1078-0432.CCR-09-0728
Publikations ID PMID: 19723645
 


Breast cancer chemoprevention - a vision not yet realized.
Autoren Blaha P, Dubsky P, Fitzal F, Bachleitner-Hofmann T, Jakesz R, Gnant M, Steger G
Erscheinungsdaten European journal of cancer care. 2009 Jul 20. pii: ECC951. doi: 10.1111/j.1365-2354.2008.00951.x
Publikations ID PMID: 19686352
 


Maintaining bone density in patients undergoing treatment for breast cancer: is there an adjuvant benefit?
Autoren Gnant M, Dubsky P, Fitzal F, Blaha P, Schoppmann S, Steger G, Marth C, Samonigg H, Hüttner K, Fohler H, Ruecklinger E, Jakesz R, Greil R
Erscheinungsdaten Clinical breast cancer. 2009 Jun 29. pii: E14888G576571X30. doi: 10.3816/CBC.2009.s.002
Publikations ID PMID: 19561003
 


Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma.
Autoren Bachleitner-Hofmann T, Friedl J, Hassler M, Hayden H, Dubsky P, Sachet M, Rieder E, Pfragner R, Brostjan C, Riss S, Niederle B, Gnant M, Stift A
Erscheinungsdaten Oncology reports. 2009 May 8.
Publikations ID PMID: 19424640
 


Endocrine therapy plus zoledronic acid in premenopausal breast cancer.
Autoren Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Pöstlberger S, Menzel C, Jakesz R, Seifert M, Hubalek M, Bjelic-Radisic V, Samonigg H, Tausch C, Eidtmann H, Steger G, Kwasny W, Dubsky P, Fridrik M, Fitzal F, Stierer M, Rücklinger E, Greil R, Marth C
Erscheinungsdaten The New England journal of medicine. 2009 Feb 13. pii: 360/7/679. doi: 10.1056/NEJMoa0806285
Publikations ID PMID: 19213681
 


Is Endocrine Therapy Really Pleasant? Considerations about the Long-Term Use of Antihormonal Therapy and Its Benefit/Side Effect Ratio.
Autoren Blaha P, Exner R, Borgo AD, Bigenzahn S, Panhofer P, Riedl O, Schoppmann S, Bachleitner-Hofmann T, Sporn E, Pluschnig U, Fitzal F, Steger G, Jakesz R, Dubsky P, Gnant M
Erscheinungsdaten Breast care (Basel, Switzerland). 2009 Jun 23. doi: 10.1159/000227829. pmc: PMC2931002. pii: 227829
Publikations ID PMID: 21160541
 


The evolving role of zoledronic acid in early breast cancer.
Autoren Gnant M
Erscheinungsdaten OncoTargets and therapy. 2009 Feb 18. pmc: PMC2886321
Publikations ID PMID: 20616898
 


Incomplete surgical resection of ductal carcinomas in situ results in activation of ERBB2 in residual breast cancer cells.
Autoren Singer CF, Hudelist G, Fuchs EM, Köstler W, Fink-Retter A, Gschwantler-Kaulich D, Gnant M, Lamm W, Rudas M, Czerwenka K, Kubista E
Erscheinungsdaten Endocrine-related cancer. 2008 Oct 23. pii: ERC-08-0065. doi: 10.1677/ERC-08-0065
Publikations ID PMID: 18948375
 


Adjuvant endocrine therapy plus zoledronic acid in premenopausal women with early-stage breast cancer: 5-year follow-up of the ABCSG-12 bone-mineral density substudy.
Autoren Gnant M, Mlineritsch B, Luschin-Ebengreuth G, Kainberger F, Kässmann H, Piswanger-Sölkner JC, Seifert M, Ploner F, Menzel C, Dubsky P, Fitzal F, Bjelic-Radisic V, Steger G, Greil R, Marth C, Kubista E, Samonigg H, Wohlmuth P, Mittlböck M, Jakesz R
Erscheinungsdaten The Lancet. Oncology. 2008 Aug 19. pii: S1470-2045(08)70204-3. doi: 10.1016/S1470-2045(08)70204-3
Publikations ID PMID: 18718815
 


Intraoperative frozen section analysis for breast-conserving therapy in 1016 patients with breast cancer.
Autoren Riedl O, Fitzal F, Mader N, Dubsky P, Rudas M, Mittlboeck M, Gnant M, Jakesz R
Erscheinungsdaten European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2008 Aug 15. pii: S0748-7983(08)00192-3. doi: 10.1016/j.ejso.2008.05.007
Publikations ID PMID: 18706785
 


The Austrian fulvestrant registry: results from a prospective observation of fulvestrant in postmenopausal patients with metastatic breast cancer.
Autoren Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Wenzel C, Sevelda P, Thaler J, Rudas M, Pober M, Zielinski CC, Steger GG
Erscheinungsdaten Breast cancer research and treatment. 2008 Jul 26. doi: 10.1007/s10549-008-0132-0
Publikations ID PMID: 18661231
 


Anemia is a significant prognostic factor in local relapse-free survival of premenopausal primary breast cancer patients receiving adjuvant cyclophosphamide/methotrexate/5-fluorouracil chemotherapy.
Autoren Dubsky P, Sevelda P, Jakesz R, Hausmaninger H, Samonigg H, Seifert M, Denison U, Mlineritsch B, Steger G, Kwasny W, Stöger H, Bartsch R, Stierer M, Taucher S, Fridrik M, Schippinger W, Greil R, Pötter R, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Apr 2. pii: 14/7/2082. doi: 10.1158/1078-0432.CCR-07-2068
Publikations ID PMID: 18381948
 


Breast-conserving therapy for centrally located breast cancer.
Autoren Fitzal F, Mittlboeck M, Trischler H, Krois W, Nehrer G, Deutinger M, Jakesz R, Gnant M
Erscheinungsdaten Annals of surgery. 2008 Mar 31. doi: 10.1097/SLA.0b013e31815b6991. pii: 00000658-200803000-00012
Publikations ID PMID: 18376192
 


Cyclin D1 expression in breast cancer patients receiving adjuvant tamoxifen-based therapy.
Autoren Rudas M, Lehnert M, Huynh A, Jakesz R, Singer C, Lax S, Schippinger W, Dietze O, Greil R, Stiglbauer W, Kwasny W, Grill R, Stierer M, Gnant MF, Filipits M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2008 Mar 18. pii: 14/6/1767. doi: 10.1158/1078-0432.CCR-07-4122
Publikations ID PMID: 18347178
 


Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer.
Autoren Bartsch R, Wenzel C, Gampenrieder SP, Pluschnig U, Altorjai G, Rudas M, Mader RM, Dubsky P, Rottenfusser A, Gnant M, Zielinski CC, Steger GG
Erscheinungsdaten Cancer chemotherapy and pharmacology. 2008 Feb 7. doi: 10.1007/s00280-008-0682-1
Publikations ID PMID: 18256835
 


Extended adjuvant therapy with anastrozole among postmenopausal breast cancer patients: results from the randomized Austrian Breast and Colorectal Cancer Study Group Trial 6a.
Autoren Jakesz R, Greil R, Gnant M, Schmid M, Kwasny W, Kubista E, Mlineritsch B, Tausch C, Stierer M, Hofbauer F, Renner K, Dadak C, Rücklinger E, Samonigg H
Erscheinungsdaten Journal of the National Cancer Institute. 2007 Dec 11. pii: djm246. doi: 10.1093/jnci/djm246
Publikations ID PMID: 18073378
 


Allogeneic tumor lysate can serve as both antigen source and protein supplementation for dendritic cell culture.
Autoren Dubsky P, Hayden H, Sachet M, Bachleitner-Hofmann T, Hassler M, Pfragner R, Gnant M, Stift A, Friedl J
Erscheinungsdaten Cancer immunology, immunotherapy : CII. 2007 Nov 21. doi: 10.1007/s00262-007-0422-0
Publikations ID PMID: 18030468
 


Capecitabine and trastuzumab in heavily pretreated metastatic breast cancer.
Autoren Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Rudas M, Mader RM, Gnant M, Zielinski CC, Steger GG
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 Aug 6. pii: JCO.2007.11.9776. doi: 10.1200/JCO.2007.11.9776
Publikations ID PMID: 17679724
 


Her2 and progesterone receptor status are not predictive of response to fulvestrant treatment.
Autoren Bartsch R, Wenzel C, Altorjai G, Pluschnig U, Mader RM, Gnant M, Jakesz R, Rudas M, Zielinski CC, Steger GG
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2007 Aug 2. pii: 13/15/4435. doi: 10.1158/1078-0432.CCR-06-3050
Publikations ID PMID: 17671127
 


An oncoplastic procedure for central and medio-cranial breast cancer.
Autoren Fitzal F, Nehrer G, Hoch D, Riedl O, Gutharc S, Deutinger M, Jakesz R, Gnant M
Erscheinungsdaten European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2007 May 25. pii: S0748-7983(07)00179-5. doi: 10.1016/j.ejso.2007.04.004
Publikations ID PMID: 17532171
 


Pathologic complete response with six compared with three cycles of neoadjuvant epirubicin plus docetaxel and granulocyte colony-stimulating factor in operable breast cancer: results of ABCSG-14.
Autoren Steger GG, Galid A, Gnant M, Mlineritsch B, Lang A, Tausch C, Rudas M, Greil R, Wenzel C, Singer CF, Haid A, Pöstlberger S, Samonigg H, Luschin-Ebengreuth G, Kwasny W, Klug E, Kubista E, Menzel C, Jakesz R
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2007 May 21. pii: 25/15/2012. doi: 10.1200/JCO.2006.09.1777
Publikations ID PMID: 17513805
 


Overexpression of the human homologue for Caenorhabditis elegans cul-4 gene is associated with poor outcome in node-negative breast cancer.
Autoren Schindl M, Gnant M, Schoppmann SF, Horvat R, Birner P
Erscheinungsdaten Anticancer research. 2007 Apr 30.
Publikations ID PMID: 17465225
 


Breast-conserving surgery for T3/T4 breast cancer: an analysis of 196 patients.
Autoren Fitzal F, Riedl O, Wutzl L, Draxler W, Rudas M, Pluschnig U, Handl-Zeller L, Dubsky P, Bachleitner-Hofmann T, Steger G, Jakesz R, Gnant M
Erscheinungsdaten Breast cancer research and treatment. 2007 Apr 7. doi: 10.1007/s10549-006-9325-6
Publikations ID PMID: 17417725
 


The use of a breast symmetry index for objective evaluation of breast cosmesis.
Autoren Fitzal F, Krois W, Trischler H, Wutzel L, Riedl O, Kühbelböck U, Wintersteiner B, Cardoso MJ, Dubsky P, Gnant M, Jakesz R, Wild T
Erscheinungsdaten Breast (Edinburgh, Scotland). 2007 Mar 26. pii: S0960-9776(07)00042-2. doi: 10.1016/j.breast.2007.01.013
Publikations ID PMID: 17382546
 


Lumpectomy plus tamoxifen or anastrozole with or without whole breast irradiation in women with favorable early breast cancer.
Autoren Pötter R, Gnant M, Kwasny W, Tausch C, Handl-Zeller L, Pakisch B, Taucher S, Hammer J, Luschin-Ebengreuth G, Schmid M, Sedlmayer F, Stierer M, Reiner G, Kapp K, Hofbauer F, Rottenfusser A, Pöstlberger S, Haider K, Draxler W, Jakesz R
Erscheinungsdaten International journal of radiation oncology, biology, physics. 2007 Mar 23. pii: S0360-3016(07)00064-8. doi: 10.1016/j.ijrobp.2006.12.045
Publikations ID PMID: 17363187
 


Zoledronic acid prevents cancer treatment-induced bone loss in premenopausal women receiving adjuvant endocrine therapy for hormone-responsive breast cancer: a report from the Austrian Breast and Colorectal Cancer Study Group.
Autoren Gnant MF, Mlineritsch B, Luschin-Ebengreuth G, Grampp S, Kaessmann H, Schmid M, Menzel C, Piswanger-Soelkner JC, Galid A, Mittlboeck M, Hausmaninger H, Jakesz R
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2006 Dec 11. pii: JCO.2005.02.7102. doi: 10.1200/JCO.2005.02.7102
Publikations ID PMID: 17159195
 


Invasive ductal carcinoma and invasive lobular carcinoma of breast differ in response following neoadjuvant therapy with epidoxorubicin and docetaxel + G-CSF.
Autoren Wenzel C, Bartsch R, Hussian D, Pluschnig U, Altorjai G, Zielinski CC, Lang A, Haid A, Jakesz R, Gnant M, Steger GG
Erscheinungsdaten Breast cancer research and treatment. 2006 Oct 24. doi: 10.1007/s10549-006-9397-3
Publikations ID PMID: 17061042
 


Multidetector CT of pancreas: effects of contrast material flow rate and individualized scan delay on enhancement of pancreas and tumor contrast.
Autoren Schueller G, Schima W, Schueller-Weidekamm C, Weber M, Stift A, Gnant M, Prokesch R
Erscheinungsdaten Radiology. 2006 Sep 18. pii: 2412051107. doi: 10.1148/radiol.2412051107
Publikations ID PMID: 16982815
 


Breast conservation: evolution of surgical strategies.
Autoren Fitzal F, Gnant M
Erscheinungsdaten The breast journal. 2006 Sep 8. pii: TBJ330. doi: 10.1111/j.1075-122X.2006.00330.x
Publikations ID PMID: 16958997
 


Heat shock treatment of tumor lysate-pulsed dendritic cells enhances their capacity to elicit antitumor T cell responses against medullary thyroid carcinoma.
Autoren Bachleitner-Hofmann T, Strohschneider M, Krieger P, Sachet M, Dubsky P, Hayden H, Schoppmann SF, Pfragner R, Gnant M, Friedl J, Stift A
Erscheinungsdaten The Journal of clinical endocrinology and metabolism. 2006 Sep 5. pii: jc.2006-0971. doi: 10.1210/jc.2006-0971
Publikations ID PMID: 16954161
 


Switching of postmenopausal women with endocrine-responsive early breast cancer to anastrozole after 2 years' adjuvant tamoxifen: combined results of ABCSG trial 8 and ARNO 95 trial.
Autoren Jakesz R, Jonat W, Gnant M, Mittlboeck M, Greil R, Tausch C, Hilfrich J, Kwasny W, Menzel C, Samonigg H, Seifert M, Gademann G, Kaufmann M, Wolfgang J
Erscheinungsdaten Lancet (London, England). 2005 Aug 8. pii: S0140-6736(05)67059-6. doi: 10.1016/S0140-6736(05)67059-6
Publikations ID PMID: 16084253
 


Gastrointestinal autonomic nerve tumors: a surgical point of view.
Autoren Stift A, Friedl J, Gnant M, Herbst F, Jakesz R, Wenzl E
Erscheinungsdaten World journal of gastroenterology : WJG. 2004 Jul 30.
Publikations ID PMID: 15285041
 


Prognostic value of lymphangiogenesis and lymphovascular invasion in invasive breast cancer.
Autoren Schoppmann SF, Bayer G, Aumayr K, Taucher S, Geleff S, Rudas M, Kubista E, Hausmaninger H, Samonigg H, Gnant M, Jakesz R, Horvat R
Erscheinungsdaten Annals of surgery. 2004 Jul 26. pii: 00000658-200408000-00017. pmc: PMC1356408
Publikations ID PMID: 15273556
 


Dendritic cell vaccination in medullary thyroid carcinoma.
Autoren Stift A, Sachet M, Yagubian R, Bittermann C, Dubsky P, Brostjan C, Pfragner R, Niederle B, Jakesz R, Gnant M, Friedl J
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2004 May 7.
Publikations ID PMID: 15131029
 


Prognostic markers in breast cancer: the reliability of HER2/neu status in core needle biopsy of 325 patients with primary breast cancer.
Autoren Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Roka S, Bachleitner T, Kandioler D, Steger G, Mittlböck M, Jakesz R
Erscheinungsdaten Wiener klinische Wochenschrift. 2004 Mar 19.
Publikations ID PMID: 15030120
 


Influence of neoadjuvant therapy with epirubicin and docetaxel on the expression of HER2/neu in patients with breast cancer.
Autoren Taucher S, Rudas M, Mader RM, Gnant M, Sporn E, Dubsky P, Roka S, Bachleitner T, Fitzal F, Kandioler D, Wenzel C, Steger GG, Mittlböck M, Jakesz R
Erscheinungsdaten Breast cancer research and treatment. 2004 Jan 1. doi: 10.1023/B:BREA.0000004378.15859.51
Publikations ID PMID: 14703068
 


Do we need HER-2/neu testing for all patients with primary breast carcinoma?
Autoren Taucher S, Rudas M, Mader RM, Gnant M, Dubsky P, Bachleitner T, Roka S, Fitzal F, Kandioler D, Sporn E, Friedl J, Mittlböck M, Jakesz R
Erscheinungsdaten Cancer. 2003 Dec 11. doi: 10.1002/cncr.11828
Publikations ID PMID: 14669272
 


Impact of pretreatment thrombocytosis on survival in primary breast cancer.
Autoren Taucher S, Salat A, Gnant M, Kwasny W, Mlineritsch B, Menzel RC, Schmid M, Smola MG, Stierer M, Tausch C, Galid A, Steger G, Jakesz R
Erscheinungsdaten Thrombosis and haemostasis. 2003 Jun 3. doi: 10.1267/THRO03061098. pii: 03061098
Publikations ID PMID: 12783124
 


Hyperthermia improves cellular immune response to human hepatocellular carcinoma subsequent to co-culture with tumor lysate pulsed dendritic cells.
Autoren Schueller G, Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Benkoe T, Jakesz R, Gnant M
Erscheinungsdaten International journal of oncology. 2003 May 9.
Publikations ID PMID: 12739010
 


Preventive mastectomy in patients at breast cancer risk due to genetic alterations in the BRCA1 and BRCA2 gene.
Autoren Taucher S, Gnant M, Jakesz R
Erscheinungsdaten Langenbeck's archives of surgery / Deutsche Gesellschaft für Chirurgie. 2003 Feb 21. doi: 10.1007/s00423-003-0355-9
Publikations ID PMID: 12690474
 


Sequential steroid hormone receptor measurements in primary breast cancer with and without intervening primary chemotherapy.
Autoren Taucher S, Rudas M, Gnant M, Thomanek K, Dubsky P, Roka S, Bachleitner T, Kandioler D, Wenzel C, Steger G, Mittlböck M, Jakesz R
Erscheinungsdaten Endocrine-related cancer. 2003 Mar 25.
Publikations ID PMID: 12653672
 


In vivo induction of dendritic cell-mediated cytotoxicity against allogeneic pancreatic carcinoma cells.
Autoren Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Benkoe T, Brostjan C, Jakesz R, Gnant M
Erscheinungsdaten International journal of oncology. 2003 Feb 11.
Publikations ID PMID: 12579320
 


Dendritic cell-based vaccination in solid cancer.
Autoren Stift A, Friedl J, Dubsky P, Bachleitner-Hofmann T, Schueller G, Zontsich T, Benkoe T, Radelbauer K, Brostjan C, Jakesz R, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2002 Dec 30.
Publikations ID PMID: 12506182
 


Stereotactic 11-gauge vacuum-assisted breast biopsy: a validation study.
Autoren Pfarl G, Helbich TH, Riedl CC, Wagner T, Gnant M, Rudas M, Liberman L
Erscheinungsdaten AJR. American journal of roentgenology. 2002 Nov 19. doi: 10.2214/ajr.179.6.1791503
Publikations ID PMID: 12438044
 


Overexpression of hypoxia-inducible factor 1alpha is associated with an unfavorable prognosis in lymph node-positive breast cancer.
Autoren Schindl M, Schoppmann SF, Samonigg H, Hausmaninger H, Kwasny W, Gnant M, Jakesz R, Kubista E, Birner P, Oberhuber G
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2002 Jun 12.
Publikations ID PMID: 12060624
 


Stimulation of autologous antitumor T-cell responses against medullary thyroid carcinoma using tumor lysate-pulsed dendritic cells.
Autoren Bachleitner-Hofmann T, Stift A, Friedl J, Pfragner R, Radelbauer K, Dubsky P, Schüller G, Benkö T, Niederle B, Brostjan C, Jakesz R, Gnant M
Erscheinungsdaten The Journal of clinical endocrinology and metabolism. 2002 Mar 12. doi: 10.1210/jcem.87.3.8283
Publikations ID PMID: 11889172
 


Evaluation of the United States Food and Drug Administration-approved scoring and test system of HER-2 protein expression in breast cancer.
Autoren Birner P, Oberhuber G, Stani J, Reithofer C, Samonigg H, Hausmaninger H, Kubista E, Kwasny W, Kandioler-Eckersberger D, Gnant M, Jakesz R
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2001 Jun 18.
Publikations ID PMID: 11410505
 


TP53 mutation and p53 overexpression for prediction of response to neoadjuvant treatment in breast cancer patients.
Autoren Kandioler-Eckersberger D, Ludwig C, Rudas M, Kappel S, Janschek E, Wenzel C, Schlagbauer-Wadl H, Mittlböck M, Gnant M, Steger G, Jakesz R
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2000 Feb 28.
Publikations ID PMID: 10656431
 


Prognostic significance of mutations in the p53 gene, particularly in the zinc-binding domains, in lymph node- and steroid receptor positive breast cancer patients. Austrian Breast Cancer Study Group.
Autoren Kucera E, Speiser P, Gnant M, Szabo L, Samonigg H, Hausmaninger H, Mittlböck M, Fridrik M, Seifert M, Kubista E, Reiner A, Zeillinger R, Jakesz R
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 1999 Aug 23. pii: S0959804998004006
Publikations ID PMID: 10448289
 


Molecular genetic differentiation between primary lung cancers and lung metastases of other tumors.
Autoren Kandioler D, Dekan G, End A, Pasching E, Buchmayer H, Gnant M, Langmann F, Mannhalter C, Eckersberger F, Wolner E
Erscheinungsdaten The Journal of thoracic and cardiovascular surgery. 1996 Jun 3. pii: S0022522396001559
Publikations ID PMID: 8614143
 


Immediate graft function after OLT clears endotoxins.
Autoren Steininger R, Függer R, Hackl W, Hamilton G, Längle F, Herbst F, Gnant M, Sautner T, Rogy M, Schulz F
Erscheinungsdaten Transplantation proceedings. 1990 Sep 26.
Publikations ID PMID: 2389396
 


Denosumab and fracture risk in women with breast cancer - Author's reply.
Autoren Gnant M
Erscheinungsdaten Lancet (London, England). 2015 Nov 20. pii: S0140-6736(15)00975-7. doi: 10.1016/S0140-6736(15)00975-7
Publikations ID PMID: 26700393
 


Adjuvant bisphosphonates in early breast cancer: Consensus guidance for clinical practice from a European Panel.
Autoren Hadji P, Coleman RE, Wilson C, Powles TJ, Clézardin P, Aapro M, Costa L, Body JJ, Markopoulos C, Santini D, Diel I, Di Leo A, Cameron D, Dodwell D, Smith I, Gnant M, Gray R, Harbeck N, Thurlimann B, Untch M, Cortes J, Martin M, Albert US, Conte PF, Ejlertsen B, Bergh J, Kaufmann M, Holen I
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology / ESMO. 2015 Dec 17. pii: mdv617. doi: 10.1093/annonc/mdv617
Publikations ID PMID: 26681681
 


Palbociclib for the treatment of postmenopausal breast cancer - an update.
Autoren Steger GG, Gnant M, Bartsch R
Erscheinungsdaten Expert opinion on pharmacotherapy. 2016 Jan 14. doi: 10.1517/14656566.2016.1133590
Publikations ID PMID: 26679057
 


St.Gallen-2015 in Vienna: News from a successful breast cancer conference transposition!
Autoren Senn HJ, Thürlimann B, Gnant M
Erscheinungsdaten Breast (Edinburgh, Scotland). 2015 Oct 4. pii: S0960-9776(15)00168-X. doi: 10.1016/j.breast.2015.07.030
Publikations ID PMID: 26439287
 


TP53 Mutational Status and Prediction of Benefit from Adjuvant 5-Fluorouracil in Stage III Colon Cancer Patients.
Autoren Kandioler D, Mittlböck M, Kappel S, Puhalla H, Herbst F, Langner C, Wolf B, Tschmelitsch J, Schippinger W, Steger G, Hofbauer F, Samonigg H, Gnant M, Teleky B, Kührer I
Erscheinungsdaten EBioMedicine. 2015 Jun 8. doi: 10.1016/j.ebiom.2015.06.003. pii: S2352-3964(15)30035-9. pmc: PMC4563117
Publikations ID PMID: 26425688
 


Adjuvant Bisphosphonates and Breast Cancer Survival.
Autoren Strobl S, Korkmaz B, Devyatko Y, Schuetz M, Exner R, Dubsky PC, Jakesz R, Gnant M
Erscheinungsdaten Annual review of medicine. 2015 Aug 28. doi: 10.1146/annurev-med-053014-103600
Publikations ID PMID: 26332000
 


Neratinib after trastuzumab-based adjuvant therapy in patients with HER2-positive breast cancer (ExteNET): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial.
Autoren Chan A, Delaloge S, Holmes FA, Moy B, Iwata H, Harvey VJ, Robert NJ, Silovski T, Gokmen E, von Minckwitz G, Ejlertsen B, Chia SK, Mansi J, Barrios CH, Gnant M, Buyse M, Gore I, Smith J, Harker G, Masuda N, Petrakova K, Zotano AG, Iannotti N, Rodriguez G, Tassone P, Wong A, Bryce R, Ye Y, Yao B, Martin M
Erscheinungsdaten The Lancet. Oncology. 2016 Feb 10. pii: S1470-2045(15)00551-3. doi: 10.1016/S1470-2045(15)00551-3
Publikations ID PMID: 26874901
 


A Cross-Sectional Study of Patients' Satisfaction With Totally Implanted Access Ports.
Autoren Minichsdorfer C, Füreder T, Mähr B, Berghoff AS, Heynar H, Dressler A, Gnant M, Zielinski C, Bartsch R
Erscheinungsdaten Clinical journal of oncology nursing. 2016 Mar 19. doi: 10.1188/16.CJON.175-180
Publikations ID PMID: 26991711
 


Breast Cancer Is Our Global Responsibility.
Autoren Harbeck N, Gnant M, Thomssen C
Erscheinungsdaten Breast care (Basel, Switzerland). 2015 Dec 16. doi: 10.1159/000443159. pii: brc-0010-0360
Publikations ID PMID: 26989353
 


Editorial comment on 'Effects of neoadjuvant chemotherapy with or without zoledronic acid on pathological response: A meta-analysis of randomised trials'.
Autoren Gnant M
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2016 Mar 28. pii: S0959-8049(16)00124-6. doi: 10.1016/j.ejca.2016.02.009
Publikations ID PMID: 27033259
 


Prognostic impact of breast cancer subtypes in elderly patients.
Autoren Bergen ES, Tichy C, Berghoff AS, Rudas M, Dubsky P, Bago-Horvath Z, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R
Erscheinungsdaten Breast cancer research and treatment. 2016 Apr 23. doi: 10.1007/s10549-016-3787-y. pii: 10.1007/s10549-016-3787-y
Publikations ID PMID: 27107570
 


Pathological complete remission and long-term outcome-what do we know in 2016?
Autoren Gnant M, Steger GG, Bartsch R
Erscheinungsdaten The Lancet. Oncology. 2016 May 11. pii: S1470-2045(16)30038-9. doi: 10.1016/S1470-2045(16)30038-9
Publikations ID PMID: 27179401
 


Prognostic value of HMGB1 in early breast cancer patients under neoadjuvant chemotherapy.
Autoren Exner R, Sachet M, Arnold T, Zinn-Zinnenburg M, Michlmayr A, Dubsky P, Bartsch R, Steger G, Gnant M, Bergmann M, Bachleitner-Hofmann T, Oehler R
Erscheinungsdaten Cancer medicine. 2016 Jul 25. doi: 10.1002/cam4.827
Publikations ID PMID: 27457217
 


Comparative Efficacy and Safety of Adjuvant Letrozole Versus Anastrozole in Postmenopausal Patients With Hormone Receptor-Positive, Node-Positive Early Breast Cancer: Final Results of the Randomized Phase III Femara Versus Anastrozole Clinical Evaluation (FACE) Trial.
Autoren Smith I, Yardley D, Burris H, De Boer R, Amadori D, McIntyre K, Ejlertsen B, Gnant M, Jonat W, Pritchard KI, Dowsett M, Hart L, Poggio S, Comarella L, Salomon H, Wamil B, O'Shaughnessy J
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 23. doi: 10.1200/JCO.2016.69.2871
Publikations ID PMID: 28113032
 


Effect of Tailored Dose-Dense Chemotherapy vs Standard 3-Weekly Adjuvant Chemotherapy on Recurrence-Free Survival Among Women With High-Risk Early Breast Cancer: A Randomized Clinical Trial.
Autoren Foukakis T, von Minckwitz G, Bengtsson NO, Brandberg Y, Wallberg B, Fornander T, Mlineritsch B, Schmatloch S, Singer CF, Steger G, Egle D, Karlsson E, Carlsson L, Loibl S, Untch M, Hellström M, Johansson H, Anderson H, Malmström P, Gnant M, Greil R, Möbus V, Bergh J
Erscheinungsdaten JAMA. 2016 Nov 8. pii: 2579866. doi: 10.1001/jama.2016.15865
Publikations ID PMID: 27825007
 


Breast cancer.
Autoren Harbeck N, Gnant M
Erscheinungsdaten Lancet (London, England). pii: S0140-6736(16)31891-8. doi: 10.1016/S0140-6736(16)31891-8
Publikations ID PMID: 27865536
 


Brain metastasis-free survival in patients with HER2-positive metastatic breast cancer.
Autoren Berghoff A, Bago-Horvath Z, Dubsky PC, Rudas M, Pluschnig U, Rottenfusser A, Gnant M, Steger GG, Zielinski C, Bartsch R
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2016 Dec 13. pii: 10.1200/jco.2011.29.27_suppl.41
Publikations ID PMID: 27957967
 


The Austrian Fulvestrant Registry: Results from a prospective observation of fulvestrant in postmenopausal patients.
Autoren Bartsch R, Mlineritsch B, Gnant M, Niernberger T, Pluschnig U, Greil R, Pober M, Sevelda P, Thaler J, Steger GG
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.1060
Publikations ID PMID: 27951028
 


Adjuvant ovarian suppression combined with tamoxifen or anastrozole, alone or in combination with zoledronic acid, in premenopausal women with hormone-responsive, stage I and II breast cancer: First efficacy results from ABCSG-12.
Autoren Gnant M, Mlineritsch B, Schippinger W, Luschin-Ebengreuth G, Poestlberger S, Menzel C, Jakesz R, Kubista E, Marth C, Greil R
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2008 Jan 1. pii: 10.1200/jco.2008.26.15_suppl.lba4
Publikations ID PMID: 27948292
 


Incomplete surgical resection of DCIS results in activation of HER-2 in residual breast cancer cells.
Autoren Singer CF, Hudelist G, Fuchs E, Köstler W, Fink-Retter A, Gschwantler-Kaulich D, Gnant M, Lamm W, Lamm W, Rudas M, Kubista E
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.15_suppl.e22035
Publikations ID PMID: 27963151
 


Predicting response to second-line trastuzumab-based therapy in patients (pts) with HER2-positive advanced breast cancer (ABC).
Autoren Bartsch R, Wenzel C, Pluschnig U, Dubsky P, Gampenrieder SP, Rudas M, Mader R, Gnant M, Zielinski CC, Steger GG
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2009 Jan 1. pii: 10.1200/jco.2009.27.15_suppl.1090
Publikations ID PMID: 27961235
 


Everolimus in combination with exemestane in the treatment of postmenopausal women with estrogen receptor-positive metastatic breast cancer who are refractory to letrozole or anastrozole: Preliminary results of the BOLERO-2 trial.
Autoren Baselga J, Campone M, Piccart-Gebhart MJ, Burris HA, Rugo HS, Noguchi S, Gnant M, Pritchard KI, Lebrun F, Beck JT, Ito Y, Yardley DA, Deleu I, Perez A, Bachelot TD, Vittori L, Mukhopadhyay P, Weber D, Sahmoud T, Hortobagyi GN
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e11058
Publikations ID PMID: 28023426
 


Quality of life in patients with pancreatic cancer during neoadjuvant chemotherapy using gemcitabine and bevazizumab: A pilot study.
Autoren Fitzal F, Schindl M, Wrba F, Koelblinger K, Goetzinger P, Kornek G, Sahora K, Gnant M, Kuehrer I
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Apr 29. pii: 10.1200/jco.2011.29.4_suppl.330
Publikations ID PMID: 27985929
 


The role of myelosuppression in synergy between chemotherapy and anti-VEGF treatment.
Autoren Brostjan C, Starlinger P, Brugger P, Schauer D, Sommerfeldt S, Tamandl D, Kuehrer I, Schoppmann SF, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.e13527
Publikations ID PMID: 28022702
 


Systemic therapy and overall survival (OS) in patients (pts) with brain metastases from HER2-positive (HER2 ) metastatic breast cancer (MBC).
Autoren Bartsch R, Berghoff A, Pluschnig U, Bago-Horvath Z, Dubsky PC, Rottenfusser A, Wenzel C, Rudas M, Fitzal F, Dieckmann K, Gnant M, Zielinski C, Steger GG
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.597
Publikations ID PMID: 28021538
 


Impact of HER2-targeted therapy on overall survival (OS) in patients (pts) with HER2-positive (HER2 ) metastatic breast cancer (MBC).
Autoren Berghoff A, Bartsch R, Bago-Horvath Z, Dubsky PC, Rudas M, Pluschnig U, Wiltschke C, Gnant M, Steger GG, Zielinski C
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.572
Publikations ID PMID: 28021466
 


Overall survival with adjuvant zoledronic acid in patients with premenopausal breast cancer with complete endocrine blockade: Long-term results from ABCSG-12.
Autoren Gnant M, Mlineritsch B, Stoeger H, Luschin-Ebengreuth G, Poestlberger S, Dubsky PC, Jakesz R, Singer CF, Eidtmann H, Greil R
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.520
Publikations ID PMID: 28021325
 


Effect of change of body mass index (BMI) during therapy on the efficacy of endocrine therapy in premenopausal patients with breast cancer: An analysis of the ABCSG-12 trial.
Autoren Pfeiler G, Königsberg R, Mlineritsch B, Stoger H, Singer CF, Poestlberger S, Steger GG, Seifert M, Dubsky PC, Jakesz R, Samonigg H, Bjelic-Radisic V, Greil R, Marth C, Fesl C, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2011 Jan 1. pii: 10.1200/jco.2011.29.15_suppl.514
Publikations ID PMID: 28021296
 


6 vs. 3 cycles of epirubicin/docetaxel G-CSF in operable breast cancer: results of ABCSG-14.
Autoren Steger GG, Kubista E, Hausmaninger H, Gnant M, Tausch C, Lang A, Samonigg H, Galid A, Jakesz R
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2005 Jan 1. pii: 10.1200/jco.2004.22.14_suppl.553
Publikations ID PMID: 28016493
 


Characterization of patients who received prior chemotherapy for advanced breast cancer (ABC) in BOLERO-2.
Autoren Campone M, Lebrun F, Noguchi S, Pritchard KI, Burris HA, Beck JT, Ito Y, Bachelot T, Pistilli B, Melichar B, Petrakova K, Arena FP, Erdkamp F, Harb WA, Litton JK, Brechenmacher T, El-Hashimy M, Taran T, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.151
Publikations ID PMID: 28136563
 


Patient-reported physical, emotional, and social functioning in advanced breast cancer: Insights from BOLERO-2.
Autoren Hortobagyi GN, Lebrun F, Beck JT, Neven P, Baselga J, Petrakova K, Dakhil SR, Sabatini S, Komorowski A, Chouinard EE, Young RR, Gnant M, Pritchard KI, Zhang J, Ziemiecki R, Brechenmacher T, Taran T, Sahmoud T, Noguchi S
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.155
Publikations ID PMID: 28136549
 


BOLERO-2: Efficacy and safety of first-line everolimus plus exemestane in advanced breast cancer.
Autoren Campone M, Gnant M, Neven P, Pistilli B, Baselga J, Bauly H, Taran T, Sahmoud T, Hortobagyi GN
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.152
Publikations ID PMID: 28136546
 


BRCA-1 promotor methylation as predictor of benefit from adjuvant CMF in triple-negative breast cancer not responsive to taxane-based neoadjuvant chemotherapy.
Autoren Födermayr M, Sebesta M, Rudas M, Berghoff AS, Promberger R, Preusser M, Dubsky PC, Fitzal F, Gnant M, Weltermann A, Zielinski C, Steger GG, Zach O
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Jan 31. doi: 10.1200/jco.2013.31.26_suppl.148
Publikations ID PMID: 28136534
 


Pathological Complete Response to Neoadjuvant Trastuzumab Is Dependent on HER2/CEP17 Ratio in HER2-Amplified Early Breast Cancer.
Autoren Singer CF, Tan YY, Fitzal F, Steger GG, Egle D, Reiner A, Rudas M, Moinfar F, Gruber C, Petru E, Bartsch R, Tendl KA, Fuchs D, Seifert M, Exner R, Balic M, Bago-Horvath Z, Filipits M, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2017 Jan 31. pii: 1078-0432.CCR-16-2373. doi: 10.1158/1078-0432.CCR-16-2373
Publikations ID PMID: 28143867
 


Effects of everolimus (EVE) on disease progression in bone and bone markers (BMs) in patients (pts) with bone metastases (mets).
Autoren Baselga J, Rugo HS, Noguchi S, Pritchard KI, Burris HA, Piccart-Gebhart MJ, Eakle JF, Mukai H, Iwata H, El-Hashimy M, Rao S, Panneerselvam A, Taran T, Hortobagyi GN, Sahmoud T, Lebwohl DE, Gnant M
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 1. doi: 10.1200/jco.2012.30.27_suppl.102
Publikations ID PMID: 28146729
 


Safety of everolimus for women over age 65 with advanced breast cancer (BC): 12.5-month follow-up of BOLERO-2.
Autoren Burris HA, Gnant M, Baselga J, Piccart-Gebhart MJ, Noguchi S, Dakhil SR, Srimuninnimit V, Puttawibul P, Csoszi T, Heng DY, Bourgeois H, Gonzalez-Martin A, Osborne K, Mukhopadhyay P, Taran T, Campone M, Hortobagyi GN, Sahmoud T, Pritchard KI
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 1. doi: 10.1200/jco.2012.30.27_suppl.104
Publikations ID PMID: 28146724
 


BOLERO-2: Health-related quality-of-life (HRQoL) in metastatic breast cancer patients treated with everolimus and exemestane versus exemestane.
Autoren Beck JT, Baselga J, Noguchi S, Gnant M, Lebrun F, Neven P, Nunzi M, Komorowski A, Chouinard E, Young RR, Anderson I, Bennett L, Ricci JF, Hortobagyi GN, Sahmoud T, Burris HA
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 1. doi: 10.1200/jco.2012.30.27_suppl.125
Publikations ID PMID: 28146707
 


Everolimus for postmenopausal women with advanced breast cancer: Updated results of the BOLERO-2 phase III trial.
Autoren Noguchi S, Pritchard KI, Burris HA, Rugo HS, Gnant M, Hortobagyi GN, Latini L, Yardley DA, Melichar B, Petrakova K, Harb W, Feng W, Cahana A, Taran T, Campone M, Baselga J, Sahmoud T, Lebwohl DE, Piccart-Gebhart MJ
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 1. doi: 10.1200/jco.2012.30.27_suppl.99
Publikations ID PMID: 28146687
 


Invasive disease-free survival benefit following neratinib as extended adjuvant therapy in centrally-confirmed HER2+ early-stage breast cancer: The ExteNET phase III randomized placebo-controlled trial.
Autoren Martin M, Von Minckwitz G, Ejlertsen B, Chia SK, Buyse ME, Mansi J, Gnant M, Holmes FA, Moy B, Iwata H, Wong A, Lalani AS, Bryce R, Bebchuk JD, Delaloge S
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2017 Feb 2. doi: 10.1200/jco.2015.33.28_suppl.117
Publikations ID PMID: 28147820
 


262PDDOCETAXEL + TRASTUZUMAB +/- NON-PEGYLATED LIPOSOMAL DOXORUBICIN +/- BEVACIZUMAB IN THE NEOADJUVANT TREATMENT OF EARLY, HER2-POSITIVE BREAST CANCER: FIRST RESULTS OF ABCSG-32.
Autoren Steger GG, Greil R, Hubalek M, Fridrik MA, Singer C, Bartsch R, Balic M, Dubsky P, Egle D, Gampenrieder SP, Pfeiler G, Mayr D, Czech T, Rinnerthaler G, Petzer AL, Sevelda P, Lang A, Frantal S, Rudas M, Gnant M
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2240998. doi: 10.1093/annonc/mdu327.10
Publikations ID PMID: 28172028
 


366PACTIVITY OF T-DM1 IN HER2-POSITIVE BREAST CANCER BRAIN METASTASES.
Autoren Bartsch R, Berghoff AS, Vogl U, Rudas M, Bergen E, Gnant M, Dieckmann K, Pinker-Domenig K, Oehler L, Zielinski C, Steger GG, Preusser M
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Feb 7. pii: 2241105. doi: 10.1093/annonc/mdu329.16
Publikations ID PMID: 28170730
 


Regional Nodal Irradiation After Breast Conserving Surgery for Early HER2-Positive Breast Cancer: Results of a Subanalysis From the ALTTO Trial.
Autoren Gingras I, Holmes E, De Azambuja E, Nguyen DH, Izquierdo M, Anne Zujewski J, Inbar M, Naume B, Tomasello G, Gralow JR, Wolff AC, Harris L, Gnant M, Moreno-Aspitia A, Piccart MJ, Azim HA
Erscheinungsdaten Journal of the National Cancer Institute. 2017 Apr 4. pii: 3064535. doi: 10.1093/jnci/djw331
Publikations ID PMID: 28376188
 


Neoadjuvant Chemotherapy with Capecitabine, Oxaliplatin and Bevacizumab Followed by Concomitant Chemoradiation and Surgical Resection in Locally Advanced Rectal Cancer with High Risk of Recurrence - A Phase II Study.
Autoren Eisterer W, Piringer G, DE Vries A, Öfner D, Greil R, Tschmelitsch J, Samonigg H, Sölkner L, Gnant M, Thaler J
Erscheinungsdaten Anticancer research. 2017 May 6. pii: 37/5/2683. doi: 10.21873/anticanres.11617
Publikations ID PMID: 28476845
 


Objective breast symmetry analysis with the breast analyzing tool (BAT): improved tool for clinical trials.
Autoren Krois W, Romar AK, Wild T, Dubsky P, Exner R, Panhofer P, Jakesz R, Gnant M, Fitzal F
Erscheinungsdaten Breast cancer research and treatment. 2017 May 2. doi: 10.1007/s10549-017-4255-z. pii: 10.1007/s10549-017-4255-z
Publikations ID PMID: 28466122
 


Management of Aromatase Inhibitor-Associated Bone Loss (AIBL) in postmenopausal women with hormone sensitive breast cancer: Joint position statement of the IOF, CABS, ECTS, IEG, ESCEO IMS, and SIOG.
Autoren Hadji P, Aapro MS, Body JJ, Gnant M, Brandi ML, Reginster JY, Zillikens MC, Glüer CC, de Villiers T, Baber R, Roodman GD, Cooper C, Langdahl B, Palacios S, Kanis J, Al-Daghri N, Nogues X, Eriksen EF, Kurth A, Rizzoli R, Coleman RE
Erscheinungsdaten Journal of bone oncology. 2017 Mar 23. doi: 10.1016/j.jbo.2017.03.001. pii: S2212-1374(17)30025-8. pmc: PMC5384888
Publikations ID PMID: 28413771
 


Therapeutic Bone-Modifying Agents in the Nonmetastatic Breast Cancer Setting: The Controversy and a Value Assessment.
Autoren Gnant M, Van Poznak C, Schnipper L
Erscheinungsdaten American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Meeting. 2017 May 31. pii: 177357. doi: 10.14694/EDBK_177357
Publikations ID PMID: 28561722
 


St. Gallen/Vienna 2017: A Brief Summary of the Consensus Discussion about Escalation and De-Escalation of Primary Breast Cancer Treatment.
Autoren Gnant M, Harbeck N, Thomssen C
Erscheinungsdaten Breast care (Basel, Switzerland). 2017 Apr 26. doi: 10.1159/000475698. pii: brc-0012-0102. pmc: PMC5447163
Publikations ID PMID: 28559767
 


De-escalating and escalating treatments for early-stage breast cancer: the St. Gallen International Expert Consensus Conference on the Primary Therapy of Early Breast Cancer 2017.
Autoren Curigliano G, Burstein HJ, P Winer E, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Y Brucker S, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Hussein K, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Aug 25. pii: 3877632. doi: 10.1093/annonc/mdx308
Publikations ID PMID: 28838210
 


Reply to "The St. Gallen International Expert Consensus on the Primary Therapy of Early Breast Cancer 2017: the point of view of an International Panel of Experts in Radiation Oncology" by Kirova et al.
Autoren Curigliano G, Burstein HJ, Winer EP, Gnant M, Dubsky P, Loibl S, Colleoni M, Regan MM, Piccart-Gebhart M, Senn HJ, Thürlimann B, André F, Baselga J, Bergh J, Bonnefoi H, Brucker SY, Cardoso F, Carey L, Ciruelos E, Cuzick J, Denkert C, Di Leo A, Ejlertsen B, Francis P, Galimberti V, Garber J, Gulluoglu B, Goodwin P, Harbeck N, Hayes DF, Huang CS, Huober J, Khaled H, Jassem J, Jiang Z, Karlsson P, Morrow M, Orecchia R, Osborne KC, Pagani O, Partridge AH, Pritchard K, Ro J, Rutgers EJT, Sedlmayer F, Semiglazov V, Shao Z, Smith I, Toi M, Tutt A, Viale G, Watanabe T, Whelan TJ, Xu B
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2017 Sep 25. pii: 4211057. doi: 10.1093/annonc/mdx543
Publikations ID PMID: 29045519
 


Neratinib after trastuzumab-based adjuvant therapy in HER2-positive breast cancer (ExteNET): 5-year analysis of a randomised, double-blind, placebo-controlled, phase 3 trial.
Autoren Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Chia SKL, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Gokmen E, Bashford A, Ruiz Borrego M, Kim SB, Jakobsen EH, Ciceniene A, Inoue K, Overkamp F, Heijns JB, Armstrong AC, Link JS, Joy AA, Bryce R, Wong A, Moran S, Yao B, Xu F, Auerbach A, Buyse M, Chan A
Erscheinungsdaten The Lancet. Oncology. 2017 Nov 13. pii: S1470-2045(17)30717-9. doi: 10.1016/S1470-2045(17)30717-9
Publikations ID PMID: 29146401
 


Sized Influences Nodal Status in Women Aged #70 with Endocrine Responsive Breast Cancer.
Autoren Fitzal F, Helfgott R, Moinfar F, Gnant M
Erscheinungsdaten Annals of surgical oncology. 2017 Nov 20. doi: 10.1245/s10434-017-6156-0. pii: 10.1245/s10434-017-6156-0
Publikations ID PMID: 29159741
 


A prospective, multicenter pilot study to investigate the feasibility and safety of a 1-year controlled exercise training after adjuvant chemotherapy in colorectal cancer patients.
Autoren Piringer G, Fridrik M, Fridrik A, Leiherer A, Zabernigg A, Greil R, Eisterer W, Tschmelitsch J, Lang A, Frantal S, Burgstaller S, Gnant M, Thaler J
Erscheinungsdaten Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer. 2017 Nov 22. doi: 10.1007/s00520-017-3961-8. pii: 10.1007/s00520-017-3961-8
Publikations ID PMID: 29168033
 


Optimal duration of adjuvant endocrine therapy: how to apply the newest data.
Autoren Wimmer K, Strobl S, Bolliger M, Devyatko Y, Korkmaz B, Exner R, Fitzal F, Gnant M
Erscheinungsdaten Therapeutic advances in medical oncology. 2017 Oct 27. doi: 10.1177/1758834017732966. pii: 10.1177_1758834017732966. pmc: PMC5764154
Publikations ID PMID: 29344105
 


Adjuvant Bisphosphonate Therapy in Postmenopausal Breast Cancer.
Autoren Strobl S, Wimmer K, Exner R, Devyatko Y, Bolliger M, Fitzal F, Gnant M
Erscheinungsdaten Current treatment options in oncology. 2018 Mar 12. doi: 10.1007/s11864-018-0535-z. pii: 10.1007/s11864-018-0535-z
Publikations ID PMID: 29527635
 


Association of p27 and cyclin D1 expression and benefit from adjuvant trastuzumab treatment in HER2-positive early breast cancer: a TransHERA study.
Autoren Filipits M, Dafni U, Gnant M, Polydoropoulou V, Hills M, Kiermaier A, De Azambuja E, Larsimont DP, Rojo F, Viale G, Toi M, Harbeck N, Pritchard KI, Gelber RD, Dinh P, Zardavas D, Leyland-Jones B, Piccart-Gebhart M, Dowsett M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2018 Mar 12. pii: 1078-0432.CCR-17-3473. doi: 10.1158/1078-0432.CCR-17-3473
Publikations ID PMID: 29530933
 


Postmastectomy Radiation Therapy in Women with T1-T2 Tumors and 1 to 3 Positive Lymph Nodes: Analysis of the Breast International Group 02-98 Trial.
Autoren Zeidan YH, Habib JG, Ameye L, Paesmans M, de Azambuja E, Gelber RD, Campbell I, Nordenskjöld B, Gutiérez J, Anderson M, Lluch A, Gnant M, Goldhirsch A, Di Leo A, Joseph DJ, Crown J, Piccart-Gebhart M, Francis PA
Erscheinungsdaten International journal of radiation oncology, biology, physics. 2018 Feb 6. pii: S0360-3016(18)30230-X. doi: 10.1016/j.ijrobp.2018.01.105
Publikations ID PMID: 29534902
 


Randomized clinical trial of the effect of a fibrin sealant patch on pancreatic fistula formation after pancreatoduodenectomy.
Autoren Schindl M, Függer R, Götzinger P, Längle F, Zitt M, Stättner S, Kornprat P, Sahora K, Hlauschek D, Gnant M
Erscheinungsdaten The British journal of surgery. 2018 Apr 17. doi: 10.1002/bjs.10840
Publikations ID PMID: 29664999
 


Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Autoren Fitzal F, Bjelic-Radisic V, Knauer M, Steger G, Hubalek M, Balic M, Singer C, Bartsch R, Schrenk P, Soelkner L, Greil R, Gnant M
Erscheinungsdaten Annals of surgery. 2018 Apr 24. doi: 10.1097/SLA.0000000000002771
Publikations ID PMID: 29697452
 


PD-L1 expression is an independent predictor of favorable outcome in patients with localized esophageal adenocarcinoma.
Autoren Kollmann D, Ignatova D, Jedamzik J, Chang YT, Jomrich G, Baierl A, Kazakov D, Michal M, French LE, Hoetzenecker W, Schatton T, Asari R, Preusser M, Gnant M, Guenova E, Schoppmann SF
Erscheinungsdaten Oncoimmunology. 2018 Mar 13. doi: 10.1080/2162402X.2018.1435226. pii: 1435226. pmc: PMC5980377
Publikations ID PMID: 29872575
 


Circulating Free Methylated Tumor DNA Markers for Sensitive Assessment of Tumor Burden and Early Response Monitoring in Patients Receiving Systemic Chemotherapy for Colorectal Cancer Liver Metastasis.
Autoren Bhangu JS, Beer A, Mittlböck M, Tamandl D, Pulverer W, Taghizadeh H, Stremitzer S, Kaczirek K, Gruenberger T, Gnant M, Bergmann M, Mannhalter C, Weinhäusel A, Oehler R, Bachleitner-Hofmann T
Erscheinungsdaten Annals of surgery. 2018 Aug 3. doi: 10.1097/SLA.0000000000002901
Publikations ID PMID: 30080722
 


TP53 is not a prognostic marker-clinical consequences of a generally disregarded fact.
Autoren Braunschmid T, Kührer I, Mittlböck M, Westerhoff M, Kappel-Latif S, Brammen L, Krishnadath KK, Phillips WA, Gnant M, Kandioler D
Erscheinungsdaten Annals of the New York Academy of Sciences. 2018 Aug 15. doi: 10.1111/nyas.13947
Publikations ID PMID: 30112858
 


Oncoplastic Breast Consortium consensus conference on nipple-sparing mastectomy.
Autoren Weber WP, Haug M, Kurzeder C, Bjelic-Radisic V, Koller R, Reitsamer R, Fitzal F, Biazus J, Brenelli F, Urban C, Paulinelli RR, Blohmer JU, Heil J, Hoffmann J, Matrai Z, Catanuto G, Galimberti V, Gentilini O, Barry M, Hadar T, Allweis TM, Olsha O, Cardoso MJ, Gouveia PF, Rubio IT, de Boniface J, Svensjö T, Bucher S, Dubsky P, Farhadi J, Fehr MK, Fulco I, Ganz-Blättler U, Günthert A, Harder Y, Hauser N, Kappos EA, Knauer M, Landin J, Mechera R, Meani F, Montagna G, Ritter M, Saccilotto R, Schwab FD, Steffens D, Tausch C, Zeindler J, Soysal SD, Lohsiriwat V, Kovacs T, Tansley A, Wyld L, Romics L, El-Tamer M, Pusic AL, Sacchini V, Gnant M
Erscheinungsdaten Breast cancer research and treatment. 2018 Sep 4. doi: 10.1007/s10549-018-4937-1. pii: 10.1007/s10549-018-4937-1
Publikations ID PMID: 30182349
 


Evolution of Targeted Therapy in Breast Cancer: Where Precision Medicine Began.
Autoren Meisel JL, Venur VA, Gnant M, Carey L
Erscheinungsdaten American Society of Clinical Oncology educational book. American Society of Clinical Oncology. Annual Meeting. doi: 10.1200/EDBK_201037
Publikations ID PMID: 30231395
 


Dose tailoring of adjuvant chemotherapy for breast cancer based on hematologic toxicities: Further results from the prospective PANTHER study with focus on obese patients.
Autoren Matikas A, Foukakis T, Moebus V, Greil R, Bengtsson NO, Steger GG, Untch M, Johansson H, Hellström M, Malmström P, Gnant M, Loibl S, Bergh J
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2018 Oct 24. pii: 5144113. doi: 10.1093/annonc/mdy475
Publikations ID PMID: 30357310
 


ERRα promotes breast cancer cell dissemination to bone by increasing RANK expression in primary breast tumors.
Autoren Vargas G, Bouchet M, Bouazza L, Reboul P, Boyault C, Gervais M, Kan C, Benetollo C, Brevet M, Croset M, Mazel M, Cayrefourcq L, Geraci S, Vacher S, Pantano F, Filipits M, Driouch K, Bieche I, Gnant M, Jacot W, Aubin JE, Duterque-Coquillaud M, Alix-Panabières C, Clézardin P, Bonnelye E
Erscheinungsdaten Oncogene. 2018 Nov 26. doi: 10.1038/s41388-018-0579-3. pii: 10.1038/s41388-018-0579-3
Publikations ID PMID: 30478447
 


Tailored axillary surgery with or without axillary lymph node dissection followed by radiotherapy in patients with clinically node-positive breast cancer (TAXIS): study protocol for a multicenter, randomized phase-III trial.
Autoren Henke G, Knauer M, Ribi K, Hayoz S, Gérard MA, Ruhstaller T, Zwahlen DR, Muenst S, Ackerknecht M, Hawle H, Fitzal F, Gnant M, Mátrai Z, Ballardini B, Gyr A, Kurzeder C, Weber WP
Erscheinungsdaten Trials. 2018 Dec 4. doi: 10.1186/s13063-018-3021-9. pii: 10.1186/s13063-018-3021-9
Publikations ID PMID: 30514362
 


The ASAMET trial: a randomized, phase II, double-blind, placebo-controlled, multicenter, 2 × 2 factorial biomarker study of tertiary prevention with low-dose aspirin and metformin in stage I-III colorectal cancer patients.
Autoren Petrera M, Paleari L, Clavarezza M, Puntoni M, Caviglia S, Briata IM, Oppezzi M, Mislej EM, Stabuc B, Gnant M, Bachleitner-Hofmann T, Roth W, Scherer D, Haefeli WE, Ulrich CM, DeCensi A
Erscheinungsdaten BMC cancer. 2018 Dec 4. doi: 10.1186/s12885-018-5126-7. pii: 10.1186/s12885-018-5126-7
Publikations ID PMID: 30514262
 


• Pancho trial (p53-adapted neoadjuvant chemotherapy for resectable esophageal cancer) completed-mutation rate of the marker higher than expected.
Autoren Kappel-Latif S, Zacherl J, Hejna M, Westerhoff M, Tamandl D, Ba-Ssalamah A, Mittlböck M, Wolf B, Wrba F, Kührer I, Pluschnig U, Schoppmann SF, Függer R, Zwrtek R, Glaser K, Karner J, Längle F, Wenzl E, Roka R, Öfner D, Tschmelitsch J, Hold M, Keil F, Gnant M, Kandioler D
Erscheinungsdaten European surgery : ACA : Acta chirurgica Austriaca. 2018 Jun 11. doi: 10.1007/s10353-018-0527-z. pii: 527. pmc: PMC6290852
Publikations ID PMID: 30559831
 


Continued endocrine therapy is associated with improved survival in patients with breast cancer brain metastases.
Autoren Bergen ES, Berghoff AS, Medjedovic M, Rudas M, Fitzal F, Bago-Horvath Z, Dieckmann K, Mader RM, Exner R, Gnant M, Zielinski CC, Steger GG, Preusser M, Bartsch R
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Jan 15. pii: 1078-0432.CCR-18-1968. doi: 10.1158/1078-0432.CCR-18-1968
Publikations ID PMID: 30647078
 


Effects of Neratinib on Health-Related Quality-of-Life in Women with HER2-Positive Early-Stage Breast Cancer: Longitudinal Analyses from the Randomized Phase III ExteNET Trial.
Autoren Delaloge S, Cella D, Ye Y, Buyse M, Chan A, Barrios CH, Holmes FA, Mansi J, Iwata H, Ejlertsen B, Moy B, Chia SKL, Gnant M, Smichkoska S, Ciceniene A, Martinez N, Filipovic S, Ben-Baruch NE, Joy AA, Langkjer ST, Senecal F, de Boer RH, Moran S, Yao B, Bryce R, Auerbach A, Fallowfield L, Martin M
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Jan 23. pii: 5299438. doi: 10.1093/annonc/mdz016
Publikations ID PMID: 30689703
 


A Phase II Randomized Study of Neoadjuvant Letrozole Plus Alpelisib for Hormone Receptor-Positive, Human Epidermal Growth Factor Receptor 2-Negative Breast Cancer (NEO-ORB).
Autoren Mayer IA, Prat A, Egle D, Blau S, Perez Fidalgo JA, Gnant M, Fasching PA, Colleoni M, Wolff AC, Winer EP, Singer CF, Hurvitz SA, Garcia Estevez L, van Dam PA, Kümmel S, Mundhenke C, Holmes FA, Babbar N, Charbonnier L, Diaz-Padilla I, Vogl FD, Sellami D, Arteaga CL
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 Feb 5. pii: 1078-0432.CCR-18-3160. doi: 10.1158/1078-0432.CCR-18-3160
Publikations ID PMID: 30723140
 


Adjuvant denosumab in postmenopausal patients with hormone receptor-positive breast cancer (ABCSG-18): disease-free survival results from a randomised, double-blind, placebo-controlled, phase 3 trial.
Autoren Gnant M, Pfeiler G, Steger GG, Egle D, Greil R, Fitzal F, Wette V, Balic M, Haslbauer F, Melbinger-Zeinitzer E, Bjelic-Radisic V, Jakesz R, Marth C, Sevelda P, Mlineritsch B, Exner R, Fesl C, Frantal S, Singer CF
Erscheinungsdaten The Lancet. Oncology. 2019 Feb 19. pii: S1470-2045(18)30862-3. doi: 10.1016/S1470-2045(18)30862-3
Publikations ID PMID: 30795951
 


PIK3CA alterations and benefit with neratinib: analysis from the randomized, double-blind, placebo-controlled, phase III ExteNET trial.
Autoren Chia SKL, Martin M, Holmes FA, Ejlertsen B, Delaloge S, Moy B, Iwata H, von Minckwitz G, Mansi J, Barrios CH, Gnant M, Tomašević Z, Denduluri N, Šeparović R, Kim SB, Jakobsen EH, Harvey V, Robert N, Smith J, Harker G, Zhang B, Eli LD, Ye Y, Lalani AS, Buyse M, Chan A
Erscheinungsdaten Breast cancer research : BCR. 2019 Mar 11. doi: 10.1186/s13058-019-1115-2. pii: 10.1186/s13058-019-1115-2
Publikations ID PMID: 30867034
 


Systemic Immune-Inflammation Index (SII) Predicts Poor Survival in Pancreatic Cancer Patients Undergoing Resection.
Autoren Jomrich G, Gruber ES, Winkler D, Hollenstein M, Gnant M, Sahora K, Schindl M
Erscheinungsdaten Journal of gastrointestinal surgery : official journal of the Society for Surgery of the Alimentary Tract. 2019 Mar 28. doi: 10.1007/s11605-019-04187-z. pii: 10.1007/s11605-019-04187-z
Publikations ID PMID: 30923999
 


Prediction of chemotherapy benefit by EndoPredict in patients with breast cancer who received adjuvant endocrine therapy plus chemotherapy or endocrine therapy alone.
Autoren Sestak I, Martín M, Dubsky P, Kronenwett R, Rojo F, Cuzick J, Filipits M, Ruiz A, Gradishar W, Soliman H, Schwartzberg L, Buus R, Hlauschek D, Rodríguez-Lescure A, Gnant M
Erscheinungsdaten Breast cancer research and treatment. 2019 Apr 30. doi: 10.1007/s10549-019-05226-8. pii: 10.1007/s10549-019-05226-8
Publikations ID PMID: 31041683
 


Denosumab in early-stage breast cancer - Authors' reply.
Autoren Gnant M, Pfeiler G, Frantal S
Erscheinungsdaten The Lancet. Oncology. pii: S1470-2045(19)30228-1. doi: 10.1016/S1470-2045(19)30228-1
Publikations ID PMID: 31044698
 


Sarcopenia and sarcopenic obesity are independent adverse prognostic factors in resectable pancreatic ductal adenocarcinoma.
Autoren Gruber ES, Jomrich G, Tamandl D, Gnant M, Schindl M, Sahora K
Erscheinungsdaten PloS one. 2019 May 6. doi: 10.1371/journal.pone.0215915. pii: PONE-D-18-32473
Publikations ID PMID: 31059520
 


Prediction of Distant Recurrence using EndoPredict among Women with ER+, HER2- Node-Positive and Node-Negative Breast Cancer Treated with Endocrine Therapy Only.
Autoren Filipits M, Dubsky P, Rudas M, Greil R, Balic M, Bago-Horvath Z, Singer CF, Hlauschek D, Brown K, Bernhisel R, Kronenwett R, Lancaster JM, Fitzal F, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2019 May 7. pii: 1078-0432.CCR-19-0376. doi: 10.1158/1078-0432.CCR-19-0376
Publikations ID PMID: 31064782
 


Impact of Breast Surgery in Primary Metastasized Breast Cancer: Outcomes of the Prospective Randomized Phase III ABCSG-28 POSYTIVE Trial.
Autoren Fitzal F, Bjelic-Radisic V, Knauer M, Steger G, Hubalek M, Balic M, Singer C, Bartsch R, Schrenk P, Soelkner L, Greil R, Gnant M
Erscheinungsdaten Annals of surgery. doi: 10.1097/SLA.0000000000002771. pii: 00000658-201906000-00024
Publikations ID PMID: 31082916
 


The 3-60 criteria challenge established predictors of postoperative mortality and enable timely therapeutic intervention after liver resection.
Autoren Gyoeri GP, Pereyra D, Braunwarth E, Ammann M, Jonas P, Offensperger F, Klinglmueller F, Baumgartner R, Holzer S, Gnant M, Laengle F, Staettner S, Gruenberger T, Starlinger P
Erscheinungsdaten Hepatobiliary surgery and nutrition. doi: 10.21037/hbsn.2019.02.01. pii: hbsn-08-02-111. pmc: PMC6503244
Publikations ID PMID: 31098358
 


Stromal coexpression of uPA/PAI-1 protein predicts poor disease outcome in endocrine-treated postmenopausal patients with receptor-positive early breast cancer.
Autoren Singer CF, Filipits M, Jahn SW, Abete L, Jakesz R, Greil R, Bauernhofer T, Kwasny W, Seifert M, Fitzal F, Kastner M, Schmitt M, Moinfar F, Gnant M
Erscheinungsdaten Breast (Edinburgh, Scotland). 2019 May 3. pii: S0960-9776(19)30501-6. doi: 10.1016/j.breast.2019.05.007
Publikations ID PMID: 31132475
 


New evidence and hope for young patients with breast cancer.
Autoren Gnant M
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2019 Jul 30. pii: S0959-8049(19)30375-2. doi: 10.1016/j.ejca.2019.06.007
Publikations ID PMID: 31374402
 


Estimating the Benefits of Therapy for Early Stage Breast Cancer The St Gallen International Consensus Guidelines for the Primary Therapy of Early Breast Cancer 2019.
Autoren Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Aug 2. pii: 5543097. doi: 10.1093/annonc/mdz235
Publikations ID PMID: 31373601
 


Neoadjuvant letrozole plus taselisib versus letrozole plus placebo in postmenopausal women with oestrogen receptor-positive, HER2-negative, early-stage breast cancer (LORELEI): a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial.
Autoren Saura C, Hlauschek D, Oliveira M, Zardavas D, Jallitsch-Halper A, de la Peña L, Nuciforo P, Ballestrero A, Dubsky P, Lombard JM, Vuylsteke P, Castaneda CA, Colleoni M, Santos Borges G, Ciruelos E, Fornier M, Boer K, Bardia A, Wilson TR, Stout TJ, Hsu JY, Shi Y, Piccart M, Gnant M, Baselga J, de Azambuja E
Erscheinungsdaten The Lancet. Oncology. 2019 Aug 8. pii: S1470-2045(19)30334-1. doi: 10.1016/S1470-2045(19)30334-1
Publikations ID PMID: 31402321
 


Breast cancer.
Autoren Harbeck N, Penault-Llorca F, Cortes J, Gnant M, Houssami N, Poortmans P, Ruddy K, Tsang J, Cardoso F
Erscheinungsdaten Nature reviews. Disease primers. 2019 Sep 23. doi: 10.1038/s41572-019-0111-2. pii: 10.1038/s41572-019-0111-2
Publikations ID PMID: 31548545
 


Challenges and Controversies in Breast Surgery.
Autoren Gnant M
Erscheinungsdaten Breast care (Basel, Switzerland). 2019 Aug 7. doi: 10.1159/000502134. pii: brc-0014-0185. pmc: PMC6751473
Publikations ID PMID: 31558891
 


Neutropenic complications in the PANTHER phase III study of adjuvant tailored dose-dense chemotherapy in early breast cancer.
Autoren Papakonstantinou A, Hedayati E, Hellström M, Johansson H, Gnant M, Steger G, Greil R, Untch M, Moebus V, Loibl S, Foukakis T, Bergh J, Matikas A
Erscheinungsdaten Acta oncologica (Stockholm, Sweden). 2019 Oct 4. doi: 10.1080/0284186X.2019.1670353
Publikations ID PMID: 31583943
 


Recurrence of breast cancer after regional or general anaesthesia: a randomised controlled trial.
Autoren Sessler DI, Pei L, Huang Y, Fleischmann E, Marhofer P, Kurz A, Mayers DB, Meyer-Treschan TA, Grady M, Tan EY, Ayad S, Mascha EJ, Buggy DJ
Erscheinungsdaten Lancet (London, England). 2019 Oct 18. pii: S0140-6736(19)32313-X. doi: 10.1016/S0140-6736(19)32313-X
Publikations ID PMID: 31645288
 


The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer.
Autoren Gruber ES, Oberhuber G, Birner P, Schlederer M, Kenn M, Schreiner W, Jomrich G, Schoppmann SF, Gnant M, Tse W, Kenner L
Erscheinungsdaten Cells. 2019 Oct 30. pii: cells8111357. doi: 10.3390/cells8111357
Publikations ID PMID: 31671695
 


St. Gallen/Vienna 2019: A Brief Summary of the Consensus Discussion on the Optimal Primary Breast Cancer Treatment.
Autoren Balic M, Thomssen C, Würstlein R, Gnant M, Harbeck N
Erscheinungsdaten Breast care (Basel, Switzerland). 2019 Apr 4. doi: 10.1159/000499931. pii: brc-0014-0103. pmc: PMC6886108
Publikations ID PMID: 31798382
 


Efficacy and Safety of Tailored and Dose-Dense Adjuvant Chemotherapy and Trastuzumab for Resected HER2-Positive Breast Cancer: Results From the Phase 3 PANTHER Trial.
Autoren Papakonstantinou A, Matikas A, Bengtsson NO, Malmström P, Hedayati E, Steger G, Untch M, Hübbert L, Johansson H, Hellström M, Gnant M, Loibl S, Greil R, Moebus V, Foukakis T, Bergh J
Erscheinungsdaten Cancer. 2019 Dec 18. doi: 10.1002/cncr.32653
Publikations ID PMID: 31851385
 


The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection.
Autoren Gruber ES, Jomrich G, Kaider A, Gnant M, Sahora K, Schindl M
Erscheinungsdaten Annals of surgical oncology. 2020 Jan 3. doi: 10.1245/s10434-019-08161-6. pii: 10.1245/s10434-019-08161-6
Publikations ID PMID: 31900809
 


Endocrine therapy with or without whole breast irradiation in low-risk breast cancer patients after breast-conserving surgery: 10-year results of the Austrian Breast and Colorectal Cancer Study Group 8A trial.
Autoren Fastner G, Sedlmayer F, Widder J, Metz M, Geinitz H, Kapp K, Fesl C, Sölkner L, Greil R, Jakesz R, Kwasny W, Heck D, Bjelic-Radisic V, Balic M, Stöger H, Wieder U, Zwrtek R, Semmler D, Horvath W, Melbinger-Zeinitzer E, Wiesholzer M, Wette V, Gnant M
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2020 Jan 18. pii: S0959-8049(19)30873-1. doi: 10.1016/j.ejca.2019.11.024
Publikations ID PMID: 31962198
 


Estimating the benefits of therapy for early-stage breast cancer: the St. Gallen International Consensus Guidelines for the primary therapy of early breast cancer 2019.
Autoren Burstein HJ, Curigliano G, Loibl S, Dubsky P, Gnant M, Poortmans P, Colleoni M, Denkert C, Piccart-Gebhart M, Regan M, Senn HJ, Winer EP, Thurlimann B
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 27. pii: S0923-7534(19)60978-6. doi: 10.1093/annonc/mdz235
Publikations ID PMID: 31987446
 


Effects of neratinib on health-related quality of life in women with HER2-positive early-stage breast cancer: longitudinal analyses from the randomized phase III ExteNET trial.
Autoren Delaloge S, Cella D, Ye Y, Buyse M, Chan A, Barrios CH, Holmes FA, Mansi J, Iwata H, Ejlertsen B, Moy B, Chia SKL, Gnant M, Smichkoska S, Ciceniene A, Martinez N, Filipović S, Ben-Baruch NE, Joy AA, Langkjer ST, Senecal F, de Boer RH, Moran S, Yao B, Bryce R, Auerbach A, Fallowfield L, Martin M
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)31112-3. doi: 10.1093/annonc/mdz016
Publikations ID PMID: 31987273
 


The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.
Autoren Hadji P, Coleman R, Gnant M, Green J
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2019 Dec 4. pii: S0923-7534(19)37530-1. doi: 10.1093/annonc/mds169
Publikations ID PMID: 32018729
 


Efficacy and safety of everolimus plus exemestane in patients with HR+, HER2- advanced breast cancer progressing on/after prior endocrine therapy in routine clinical practice: Primary results from the non-interventional study, STEPAUT.
Autoren Steger GG, Egle D, Bartsch R, Pfeiler G, Petru E, Greil R, Helfgott R, Marth C, Öhler L, Hubalek M, Lang A, Tinchon C, Haslbauer F, Redl A, Hock K, Hennebelle M, Mraz B, Gnant M
Erscheinungsdaten Breast (Edinburgh, Scotland). 2020 Jan 31. pii: S0960-9776(20)30036-9. doi: 10.1016/j.breast.2020.01.035
Publikations ID PMID: 32062536
 


Prognostic value of endopredict for invasive lobular carcinomas in the combined ABCSG-6/8 and TransATAC trials.
Autoren Sestak I, Filipits M, Buus R, Rudas M, Knauer M, Kronenwett R, Cuzick J, Gnant MI, Dowsett M, Dubsky P
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2020 Jan 8. pii: S0923-7534(19)30274-1. doi: 10.1093/annonc/mdz095.001
Publikations ID PMID: 32084704
 


mRNA expression of ER, PR, HER2 and Ki67 are concordant to central ihc and predict clinical outcome: A validation study from the ABCSG-6 biomarker cohort.
Autoren Filipits M, Rudas M, Singer C, Bago-Horvath Z, Greil R, Balic M, Lax SF, Wu N, Zhao S, Weidler J, Bates M, Hlauschek D, Gnant M, Dubsky P
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)49954-7. doi: 10.1093/annonc/mdy294.003
Publikations ID PMID: 32137237
 


Androgen receptor expression in breast cancer brain metastases.
Autoren Bergen ES, Berghoff ASS, Rajky U, Rudas M, Bago-Horvath Z, Exner R, Dieckmann K, Widhalm G, Gnant MI, Zielinski CC, Steger GG, Preusser M, Bartsch R
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. pii: S0923-7534(19)48796-6. doi: 10.1093/annonc/mdy273.367
Publikations ID PMID: 32136166
 


Long-term (up to 16 months) health-related quality of life after adjuvant tailored dose-dense chemotherapy vs. standard three-weekly chemotherapy in women with high-risk early breast cancer.
Autoren Brandberg Y, Johansson H, Hellström M, Gnant M, Möbus V, Greil R, Foukakis T, Bergh J
Erscheinungsdaten Breast cancer research and treatment. 2020 Mar 31. doi: 10.1007/s10549-020-05602-9. pii: 10.1007/s10549-020-05602-9
Publikations ID PMID: 32232698
 


Efficacy and safety of the therapeutic cancer vaccine tecemotide (L-BLP25) in early breast cancer: Results from a prospective, randomised, neoadjuvant phase II study (ABCSG 34).
Autoren Singer CF, Pfeiler G, Hubalek M, Bartsch R, Stöger H, Pichler A, Petru E, Bjelic-Radisic V, Greil R, Rudas M, Maria Tea MK, Wette V, Petzer AL, Sevelda P, Egle D, Dubsky PC, Filipits M, Fitzal F, Exner R, Jakesz R, Balic M, Tinchon C, Bago-Horvath Z, Frantal S, Gnant M
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2020 Apr 20. pii: S0959-8049(20)30159-3. doi: 10.1016/j.ejca.2020.03.018
Publikations ID PMID: 32325419
 


Incidence and time course of everolimus-related adverse events in postmenopausal women with hormone receptor-positive advanced breast cancer: insights from BOLERO-2.
Autoren Rugo HS, Pritchard KI, Gnant M, Noguchi S, Piccart M, Hortobagyi G, Baselga J, Perez A, Geberth M, Csoszi T, Chouinard E, Srimuninnimit V, Puttawibul P, Eakle J, Feng W, Bauly H, El-Hashimy M, Taran T, Burris HA
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2014 Mar 10. pii: S0923-7534(19)36498-1. doi: 10.1093/annonc/mdu009. pmc: PMC3969554
Publikations ID PMID: 24615500
 


Present and future breast cancer management--bench to bedside and back: a positioning paper of academia, regulatory authorities and pharmaceutical industry.
Autoren Bartsch R, Frings S, Marty M, Awada A, Berghoff AS, Conte P, Dickin S, Enzmann H, Gnant M, Hasmann M, Hendriks HR, Llombart A, Massacesi C, von Minckwitz G, Penault-Llorca F, Scaltriti M, Yarden Y, Zwierzina H, Zielinski CC
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2013 Dec 18. pii: S0923-7534(19)36495-6. doi: 10.1093/annonc/mdt531
Publikations ID PMID: 24351401
 


Primary surgery versus no surgery in synchronous metastatic breast cancer: patient-reported quality-of-life outcomes of the prospective randomized multicenter ABCSG-28 Posytive Trial.
Autoren Bjelic-Radisic V, Fitzal F, Knauer M, Steger G, Egle D, Greil R, Schrenk P, Balic M, Singer C, Exner R, Soelkner L, Gnant M
Erscheinungsdaten BMC cancer. 2020 May 6. doi: 10.1186/s12885-020-06894-2. pii: 10.1186/s12885-020-06894-2
Publikations ID PMID: 32375735
 


ESMO Management and treatment adapted recommendations in the COVID-19 era: Breast Cancer.
Autoren de Azambuja E, Trapani D, Loibl S, Delaloge S, Senkus E, Criscitiello C, Poortman P, Gnant M, Di Cosimo S, Cortes J, Cardoso F, Paluch-Shimon S, Curigliano G
Erscheinungsdaten ESMO open. pii: esmoopen-2020-000793. doi: 10.1136/esmoopen-2020-000793
Publikations ID PMID: 32439716
 


IDO1 Paneth cells promote immune escape of colorectal cancer.
Autoren Pflügler S, Svinka J, Scharf I, Crncec I, Filipits M, Charoentong P, Tschurtschenthaler M, Kenner L, Awad M, Stift J, Schernthanner M, Bischl R, Herndler-Brandstetter D, Glitzner E, Moll HP, Casanova E, Timelthaler G, Sibilia M, Gnant M, Lax S, Thaler J, Müller M, Strobl B, Mohr T, Kaser A, Trajanoski Z, Heller G, Eferl R
Erscheinungsdaten Communications biology. 2020 May 22. doi: 10.1038/s42003-020-0989-y. pii: 10.1038/s42003-020-0989-y
Publikations ID PMID: 32444775
 


The EndoPredict score predicts response to neoadjuvant chemotherapy and neoendocrine therapy in hormone receptor-positive, human epidermal growth factor receptor 2-negative breast cancer patients from the ABCSG-34 trial.
Autoren Dubsky PC, Singer CF, Egle D, Wette V, Petru E, Balic M, Pichler A, Greil R, Petzer AL, Bago-Horvath Z, Fesl C, Meek SM, Kronenwett R, Rudas M, Gnant M, Filipits M
Erscheinungsdaten European journal of cancer (Oxford, England : 1990). 2020 Jun 2. pii: S0959-8049(20)30223-9. doi: 10.1016/j.ejca.2020.04.020
Publikations ID PMID: 32502940
 


Predictive value of molecular subtypes in premenopausal women with hormone receptor-positive early breast cancer: Results from the ABCSG Trial 5.
Autoren Bago-Horvath Z, Rudas M, Singer CF, Greil R, Balic M, Lax S, Kwasny W, Hulla W, Gnant M, Filipits M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Jun 16. pii: 1078-0432.CCR-20-0673. doi: 10.1158/1078-0432.CCR-20-0673
Publikations ID PMID: 32546648
 


Prognostic Value of EndoPredict in Women with Hormone Receptor Positive, HER2-Negative Invasive Lobular Breast Cancer.
Autoren Sestak I, Filipits M, Buus R, Rudas M, Balic M, Knauer M, Kronenwett R, Fitzal F, Cuzick J, Gnant M, Greil R, Dowsett M, Dubsky P
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2020 Jun 19. pii: 1078-0432.CCR-20-0260. doi: 10.1158/1078-0432.CCR-20-0260
Publikations ID PMID: 32561662
 


The impact of menopause on bone, zoledronic acid, and implications for breast cancer growth and metastasis.
Autoren Hadji P, Coleman R, Gnant M, Green J
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2012 Jun 22. pii: S0923-7534(19)37530-1. doi: 10.1093/annonc/mds169. pmc: PMC3477882
Publikations ID PMID: 22730099
 


Management of aromatase inhibitor-associated bone loss in postmenopausal women with breast cancer: practical guidance for prevention and treatment.
Autoren Hadji P, Aapro MS, Body JJ, Bundred NJ, Brufsky A, Coleman RE, Gnant M, Guise T, Lipton A
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2011 Mar 17. pii: S0923-7534(19)34348-0. doi: 10.1093/annonc/mdr017
Publikations ID PMID: 21415233
 


Influence of a Structured Exercise Training on Patients Reported Quality of Life in Colorectal Cancer Patients After Adjuvant Chemotherapy: A Pilot Study.
Autoren Piringer G, Holzner B, Mayrbaeurl B, Heibl S, Sztankay M, Frantal S, Gnant M, Thaler J
Erscheinungsdaten Integrative cancer therapies. doi: 10.1177/1534735420938458
Publikations ID PMID: 32735463
 


Correction to: The Prognostic Index Independently Predicts Survival in Patients with Pancreatic Ductal Adenocarcinoma Undergoing Resection.
Autoren Gruber ES, Jomrich G, Kaider A, Gnant M, Sahora K, Schindl M
Erscheinungsdaten Annals of surgical oncology. 2020 Aug 5. doi: 10.1245/s10434-020-09010-7. pii: 10.1245/s10434-020-09010-7
Publikations ID PMID: 32754799
 


More is not always better-what can be learned from the D-CARE trial.
Autoren Pfeiler G, Gnant M
Erscheinungsdaten Annals of translational medicine. doi: 10.21037/atm.2020.04.31. pii: atm-08-16-1034. pmc: PMC7475453
Publikations ID PMID: 32953834
 


Virtual Science in Senology: Let Us Not Throw out the Baby with the Bathwater.
Autoren Harbeck N, Thomssen C, Gnant M
Erscheinungsdaten Breast care (Basel, Switzerland). 2020 Jul 28. doi: 10.1159/000510067. pii: brc-0015-0323. pmc: PMC7490666
Publikations ID PMID: 32982640
 


Final Efficacy Results of Neratinib in HER2-positive Hormone Receptor-positive Early-stage Breast Cancer From the Phase III ExteNET Trial.
Autoren Chan A, Moy B, Mansi J, Ejlertsen B, Holmes FA, Chia S, Iwata H, Gnant M, Loibl S, Barrios CH, Somali I, Smichkoska S, Martinez N, Alonso MG, Link JS, Mayer IA, Cold S, Murillo SM, Senecal F, Inoue K, Ruiz-Borrego M, Hui R, Denduluri N, Patt D, Rugo HS, Johnston SRD, Bryce R, Zhang B, Xu F, Wong A, Martin M
Erscheinungsdaten Clinical breast cancer. 2020 Oct 6. pii: S1526-8209(20)30258-5. doi: 10.1016/j.clbc.2020.09.014
Publikations ID PMID: 33183970
 


Erratum: Gruber, E.S.; et al. The Oncogene AF1Q is Associated with WNT and STAT Signaling and Offers a Novel Independent Prognostic Marker in Patients with Resectable Esophageal Cancer. 2019, , 1357.
Autoren Gruber ES, Oberhuber G, Birner P, Schlederer M, Kenn M, Schreiner W, Jomrich G, Schoppmann SF, Gnant M, Tse W, Kenner L
Erscheinungsdaten Cells. 2020 Dec 21. pii: cells9122724. doi: 10.3390/cells9122724
Publikations ID PMID: 33371531
 


Breast conservation and axillary management after primary systemic therapy in patients with early-stage breast cancer: the Lucerne toolbox.
Autoren Dubsky P, Pinker K, Cardoso F, Montagna G, Ritter M, Denkert C, Rubio IT, de Azambuja E, Curigliano G, Gentilini O, Gnant M, Günthert A, Hauser N, Heil J, Knauer M, Knotek-Roggenbauerc M, Knox S, Kovacs T, Kuerer HM, Loibl S, Mannhart M, Meattini I, Penault-Llorca F, Radosevic-Robin N, Sager P, Španić T, Steyerova P, Tausch C, Peeters MTFDV, Weber WP, Cardoso MJ, Poortmans P
Erscheinungsdaten The Lancet. Oncology. pii: S1470-2045(20)30580-5. doi: 10.1016/S1470-2045(20)30580-5
Publikations ID PMID: 33387500
 


A clinical validation study of MammaPrint in hormone receptor-positive breast cancer from the Austrian Breast and Colorectal Cancer Study Group 8 (ABCSG-8) biomarker cohort.
Autoren Dubsky P, Van't Veer L, Gnant M, Rudas M, Bago-Horvath Z, Greil R, Lujinovic E, Buresch J, Rinnerthaler G, Hulla W, Moinfar F, Egle D, Herz W, Dreezen C, Frantal S, Filipits M
Erscheinungsdaten ESMO open. 2020 Dec 31. pii: S2059-7029(20)32868-4. doi: 10.1016/j.esmoop.2020.100006
Publikations ID PMID: 33399073
 


Palbociclib with adjuvant endocrine therapy in early breast cancer (PALLAS): interim analysis of a multicentre, open-label, randomised, phase 3 study.
Autoren Mayer EL, Dueck AC, Martin M, Rubovszky G, Burstein HJ, Bellet-Ezquerra M, Miller KD, Zdenkowski N, Winer EP, Pfeiler G, Goetz M, Ruiz-Borrego M, Anderson D, Nowecki Z, Loibl S, Moulder S, Ring A, Fitzal F, Traina T, Chan A, Rugo HS, Lemieux J, Henao F, Lyss A, Antolin Novoa S, Wolff AC, Vetter M, Egle D, Morris PG, Mamounas EP, Gil-Gil MJ, Prat A, Fohler H, Metzger Filho O, Schwarz M, DuFrane C, Fumagalli D, Theall KP, Lu DR, Bartlett CH, Koehler M, Fesl C, DeMichele A, Gnant M
Erscheinungsdaten The Lancet. Oncology. 2021 Jan 15. pii: S1470-2045(20)30642-2. doi: 10.1016/S1470-2045(20)30642-2
Publikations ID PMID: 33460574
 


PAM-50 predicts local recurrence after breast cancer surgery in postmenopausal patients with ER+/HER2- disease: results from 1204 patients in the randomized ABCSG-8 trial.
Autoren Fitzal F, Filipits M, Fesl C, Rudas M, Greil R, Balic M, Moinfar F, Herz W, Dubsky P, Bartsch R, Ferree S, Schaper C, Gnant M
Erscheinungsdaten The British journal of surgery. 2021 Feb 20. pii: 6145316. doi: 10.1093/bjs/znaa089
Publikations ID PMID: 33608712
 


Conventional versus reverse sequence of neoadjuvant epirubicin/cyclophosphamide and docetaxel: sequencing results from ABCSG-34.
Autoren Bartsch R, Singer CF, Pfeiler G, Hubalek M, Stoeger H, Pichler A, Petru E, Bjelic-Radisic V, Greil R, Rudas M, Muy-Kheng TM, Wette V, Petzer AL, Sevelda P, Egle D, Dubsky PC, Filipits M, Fitzal F, Exner R, Jakesz R, Balic M, Tinchon C, Bago-Horvath Z, Frantal S, Gnant M
Erscheinungsdaten British journal of cancer. 2021 Mar 24. doi: 10.1038/s41416-021-01284-2. pii: 10.1038/s41416-021-01284-2
Publikations ID PMID: 33762716
 


Palbociclib for Residual High-Risk Invasive HR-Positive and HER2-Negative Early Breast Cancer-The Penelope-B Trial.
Autoren Loibl S, Marmé F, Martin M, Untch M, Bonnefoi H, Kim SB, Bear H, McCarthy N, Melé Olivé M, Gelmon K, García-Sáenz J, Kelly CM, Reimer T, Toi M, Rugo HS, Denkert C, Gnant M, Makris A, Koehler M, Huang-Bartelett C, Lechuga Frean MJ, Colleoni M, Werutsky G, Seiler S, Burchardi N, Nekljudova V, von Minckwitz G
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Apr 1. doi: 10.1200/JCO.20.03639
Publikations ID PMID: 33793299
 


St. Gallen/Vienna 2021: A Brief Summary of the Consensus Discussion on Customizing Therapies for Women with Early Breast Cancer.
Autoren Thomssen C, Balic M, Harbeck N, Gnant M
Erscheinungsdaten Breast care (Basel, Switzerland). 2021 Apr 7. doi: 10.1159/000516114. pii: brc-0016-0135. pmc: PMC8089428
Publikations ID PMID: 34002112
 


Fifteen Years of .
Autoren Thomssen C, Harbeck N, Gnant M
Erscheinungsdaten Breast care (Basel, Switzerland). 2021 Mar 26. doi: 10.1159/000515745. pii: brc-0016-0097. pmc: PMC8114040
Publikations ID PMID: 34012363
 


CUSTOMIZING LOCAL AND SYSTEMIC THERAPIES FOR WOMEN WITH EARLY BREAST CANCER: The St. Gallen International Consensus Guidelines for treatment of early breast cancer 2021.
Autoren Burstein HJ, Curigliano G, Thürlimann B, Weber WP, Poortmans P, Regan M, Senn HJ, Winer EP, Gnant M
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2021 Jul 6. pii: S0923-7534(21)02104-9. doi: 10.1016/j.annonc.2021.06.023
Publikations ID PMID: 34242744
 


Duration of Adjuvant Aromatase-Inhibitor Therapy in Postmenopausal Breast Cancer.
Autoren Gnant M, Fitzal F, Rinnerthaler G, Steger GG, Greil-Ressler S, Balic M, Heck D, Jakesz R, Thaler J, Egle D, Manfreda D, Bjelic-Radisic V, Wieder U, Singer CF, Melbinger-Zeinitzer E, Haslbauer F, Sevelda P, Trapl H, Wette V, Wimmer K, Gampenrieder SP, Bartsch R, Kacerovsky-Strobl S, Suppan C, Brunner C, Deutschmann C, Soelkner L, Fesl C, Greil R
Erscheinungsdaten The New England journal of medicine. doi: 10.1056/NEJMoa2104162
Publikations ID PMID: 34320285
 


ESR1, PGR, ERBB2, and MKi67 mRNA expression in postmenopausal women with hormone receptor-positive early breast cancer: results from ABCSG Trial 6.
Autoren Filipits M, Rudas M, Singer CF, Fitzal F, Bago-Horvath Z, Greil R, Balic M, Lax SF, Halper S, Hulla W, Wu NC, Liu X, Weidler J, Bates M, Hlauschek D, Gnant M, Dubsky P
Erscheinungsdaten ESMO open. 2021 Aug 6. pii: S2059-7029(21)00189-7. doi: 10.1016/j.esmoop.2021.100228
Publikations ID PMID: 34371382
 


The OncoMasTR test predicts distant recurrence in estrogen receptor-positive, HER2-negative early-stage breast cancer: A validation study in ABCSG Trial 8.
Autoren Filipits M, Rudas M, Kainz V, Singer CF, Fitzal F, Bago-Horvath Z, Greil R, Balic M, Regitnig P, Halper S, Hulla W, Egle D, Barron S, Loughman T, O'Leary D, Gallagher WM, Hlauschek D, Gnant M, Dubsky P
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Aug 11. pii: 1078-0432.CCR-21-1023. doi: 10.1158/1078-0432.CCR-21-1023
Publikations ID PMID: 34380638
 


Spotlight on International Quality: COVID-19 and Its Impact on Quality Improvement in Cancer Care.
Autoren Blayney DW, Bariani G, Das D, Dawood S, Gnant M, De Guzman R, Martin SE, O'Mahony D, Roach A, Ruff P, Sampaio C, Sanchez JA, Vanderpuye V, Kamal A, Hendricks C
Erscheinungsdaten JCO global oncology. doi: 10.1200/GO.21.00281
Publikations ID PMID: 34714666
 


The location of small tumor deposits in the SLN predicts Non-SLN macrometastases in breast cancer patients.
Autoren Li J, Rudas M, Kemmner W, Warnick P, Fischer J, Gnant M, Schlag PM, Bembenek A
Erscheinungsdaten European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology. 2007 Aug 30. pii: S0748-7983(07)00281-8. doi: 10.1016/j.ejso.2007.07.009
Publikations ID PMID: 17764886
 


Persistence of ctDNA in breast cancer patients during neoadjuvant treatment is a significant predictor of poor tumour response.
Autoren Zhou Q, Gampenrieder SP, Frantal S, Rinnerthaler G, Singer CF, Egle D, Pfeiler G, Bartsch R, Wette V, Pichler A, Petru E, Dubsky PC, Bago-Horvath Z, Fesl C, Rudas M, Ståhlberg A, Graf R, Weber S, Dandachi N, Filipits M, Gnant M, Balic M, Heitzer E
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2021 Dec 3. pii: 1078-0432.CCR-21-3231. doi: 10.1158/1078-0432.CCR-21-3231
Publikations ID PMID: 34862246
 


Adjuvant Palbociclib for Early Breast Cancer: The PALLAS Trial Results (ABCSG-42/AFT-05/BIG-14-03).
Autoren Gnant M, Dueck AC, Frantal S, Martin M, Burstein HJ, Greil R, Fox P, Wolff AC, Chan A, Winer EP, Pfeiler G, Miller KD, Colleoni M, Suga JM, Rubovsky G, Bliss JM, Mayer IA, Singer CF, Nowecki Z, Hahn O, Thomson J, Wolmark N, Amillano K, Rugo HS, Steger GG, Hernando Fernández de Aránguiz B, Haddad TC, Perelló A, Bellet M, Fohler H, Metzger Filho O, Jallitsch-Halper A, Solomon K, Schurmans C, Theall KP, Lu DR, Tenner K, Fesl C, DeMichele A, Mayer EL
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2021 Dec 7. doi: 10.1200/JCO.21.02554
Publikations ID PMID: 34874182
 


Treatment Exposure and Discontinuation in the PALbociclib CoLlaborative Adjuvant Study of Palbociclib With Adjuvant Endocrine Therapy for Hormone Receptor-Positive/Human Epidermal Growth Factor Receptor 2-Negative Early Breast Cancer (PALLAS/AFT-05/ABCSG-42/BIG-14-03).
Autoren Mayer EL, Fesl C, Hlauschek D, Garcia-Estevez L, Burstein HJ, Zdenkowski N, Wette V, Miller KD, Balic M, Mayer IA, Cameron D, Winer EP, Ponce Lorenzo JJ, Lake D, Pristauz-Telsnigg G, Haddad TC, Shepherd L, Iwata H, Goetz M, Cardoso F, Traina TA, Sabanathan D, Breitenstein U, Ackerl K, Metzger Filho O, Zehetner K, Solomon K, El-Abed S, Theall KP, Lu DR, Dueck A, Gnant M, DeMichele A
Erscheinungsdaten Journal of clinical oncology : official journal of the American Society of Clinical Oncology. 2022 Jan 7. doi: 10.1200/JCO.21.01918
Publikations ID PMID: 34995105
 


Safety of adjuvant CDK4/6 inhibitors during the COVID-19 pandemic.
Autoren Pfeiler G, DeMichele A, Dueck AC, Fesl C, Gnant M, Mayer EL
Erscheinungsdaten The Lancet. Oncology. pii: S1470-2045(21)00708-7. doi: 10.1016/S1470-2045(21)00708-7
Publikations ID PMID: 35114114
 


Validation of bedside ultrasound to predict lumbar muscle area in the computed tomography in 200 non-critically ill patients: The USVALID prospective study.
Autoren Fischer A, Hertwig A, Hahn R, Anwar M, Siebenrock T, Pesta M, Liebau K, Timmermann I, Brugger J, Posch M, Ringl H, Tamandl D, Hiesmayr M
Erscheinungsdaten Clinical nutrition (Edinburgh, Scotland). 2022 Feb 11. pii: S0261-5614(22)00045-0. doi: 10.1016/j.clnu.2022.01.034
Publikations ID PMID: 35263692
 


Effect of concomitant statin treatment in postmenopausal patients with hormone receptor-positive early-stage breast cancer receiving adjuvant denosumab or placebo: a post hoc analysis of ABCSG-18.
Autoren Minichsdorfer C, Fuereder T, Leutner M, Singer CF, Kacerovsky-Strobl S, Egle D, Greil R, Balic M, Fitzal F, Pfeiler G, Frantal S, Bartsch R, Gnant M
Erscheinungsdaten ESMO open. 2022 Mar 22. pii: S2059-7029(22)00047-3. doi: 10.1016/j.esmoop.2022.100426
Publikations ID PMID: 35334418
 


Oncoplastic breast consortium recommendations for mastectomy and whole breast reconstruction in the setting of post-mastectomy radiation therapy.
Autoren Weber WP, Shaw J, Pusic A, Wyld L, Morrow M, King T, Mátrai Z, Heil J, Fitzal F, Potter S, Rubio IT, Cardoso MJ, Gentilini OD, Galimberti V, Sacchini V, Rutgers EJT, Benson J, Allweis TM, Haug M, Paulinelli RR, Kovacs T, Harder Y, Gulluoglu BM, Gonzalez E, Faridi A, Elder E, Dubsky P, Blohmer JU, Bjelic-Radisic V, Barry M, Hay SD, Bowles K, French J, Reitsamer R, Koller R, Schrenk P, Kauer-Dorner D, Biazus J, Brenelli F, Letzkus J, Saccilotto R, Joukainen S, Kauhanen S, Karhunen-Enckell U, Hoffmann J, Kneser U, Kühn T, Kontos M, Tampaki EC, Carmon M, Hadar T, Catanuto G, Garcia-Etienne CA, Koppert L, Gouveia PF, Lagergren J, Svensjö T, Maggi N, Kappos EA, Schwab FD, Castrezana L, Steffens D, Krol J, Tausch C, Günthert A, Knauer M, Katapodi MC, Bucher S, Hauser N, Kurzeder C, Mucklow R, Tsoutsou PG, Sezer A, Çakmak GK, Karanlik H, Fairbrother P, Romics L, Montagna G, Urban C, Walker M, Formenti SC, Gruber G, Zimmermann F, Zwahlen DR, Kuemmel S, El-Tamer M, Vrancken Peeters MJ, Kaidar-Person O, Gnant M, Poortmans P, de Boniface J
Erscheinungsdaten Breast (Edinburgh, Scotland). 2022 Mar 18. pii: S0960-9776(22)00058-3. doi: 10.1016/j.breast.2022.03.008
Publikations ID PMID: 35366506
 


The iTOP trial: Comparing immediate techniques of oncoplastic surgery with conventional breast surgery in women with breast cance - A prospective, controlled, single-center study.
Autoren Bolliger M, Lanmüller P, Schuetz M, Heilig B, Windischbauer A, Jakesz R, Zehetgruber T, Gnant M, Gleiss A, Dörfler D, Singer C, Bartsch R, Haslik W, Montagna G, Fitzal F
Erscheinungsdaten International journal of surgery (London, England). 2022 Jun 1. pii: S1743-9191(22)00471-X. doi: 10.1016/j.ijsu.2022.106694
Publikations ID PMID: 35662621
 


Independent validation of stromal uPA in ABCSG-08: Level 1b evidence for the prognostic value of uPA immunohistochemistry.
Autoren Singer CF, Jahn SW, Rudas M, Bago-Horvath Z, Fitzal F, Abete L, Moinfar F, Gnant M, Filipits M
Erscheinungsdaten Breast (Edinburgh, Scotland). 2022 May 19. pii: S0960-9776(22)00095-9. doi: 10.1016/j.breast.2022.05.003
Publikations ID PMID: 35689881
 


Influence of Height on Risk and Outcome of Patients with Early Breast Cancer: A Pooled Analysis of 4,925 Patients from 5 Randomized Trials of the Austrian Breast and Colorectal Cancer Study Group (ABCSG).
Autoren Gampenrieder SP, Pircher M, Fesl C, Rinnerthaler G, Mlineritsch B, Greil-Ressler S, Steger GG, Sagaster V, Fitzal F, Exner R, Devyatko Y, Balic M, Stöger H, Suppan C, Bauernhofer T, Singer CF, Pfeiler G, Seifert M, Helfgott R, Heck D, Rumpold H, Kwasny W, Wieder U, Gnant M, Greil R
Erscheinungsdaten Breast care (Basel, Switzerland). 2021 May 21. doi: 10.1159/000516157. pii: brc-0017-0137. pmc: PMC9149458
Publikations ID PMID: 35707180
 


Estrogen Receptor Alpha Gene Amplification Is an Independent Predictor of Long-Term Outcome in Postmenopausal Patients with Endocrine-Responsive Early Breast Cancer.
Autoren Singer CF, Holst F, Steurer S, Burandt EC, Lax SF, Jakesz R, Rudas M, Stöger H, Greil R, Sauter G, Filipits M, Simon R, Gnant M
Erscheinungsdaten Clinical cancer research : an official journal of the American Association for Cancer Research. 2022 Aug 3. pii: 707422. doi: 10.1158/1078-0432.CCR-21-4328
Publikations ID PMID: 35920686
 


Breast surgery after neoadjuvant therapy.
Autoren Gnant M
Erscheinungsdaten Current opinion in oncology. 2022 Sep 8. doi: 10.1097/CCO.0000000000000906. pii: 00001622-990000000-00046
Publikations ID PMID: 36083127
 


Cost-effectiveness of palbociclib in early breast cancer patients with a high risk of relapse: Results from the PENELOPE-B trial.
Autoren Galactionova K, Loibl S, Salari P, Marmé F, Martin M, Untch M, Bonnefoi HR, Kim SB, Bear HD, McCarthy N, Gelmon KA, García-Sáenz JA, Kelly CM, Reimer T, Toi M, Rugo HS, Gnant M, Makris A, Burchardi N, Schwenkglenks M
Erscheinungsdaten Frontiers in oncology. 2022 Sep 5. doi: 10.3389/fonc.2022.886831. pmc: PMC9484462
Publikations ID PMID: 36132153
 


Austrian treatment algorithms in HER2-positive metastatic breast cancer: a 2022 update.
Autoren Rinnerthaler G, Singer C, Petru E, Egle D, Petzer A, Pluschnig U, Gampenrieder SP, Pfeiler G, Gnant M, Grünberger B, Krippl P, Strasser-Weippl K, Suppan C, Brunner C, Pusch R, Sandholzer M, Balic M, Bartsch R
Erscheinungsdaten Wiener klinische Wochenschrift. 2022 Sep 23. doi: 10.1007/s00508-022-02082-3. pii: 10.1007/s00508-022-02082-3
Publikations ID PMID: 36149495
 


Overall survival in the OlympiA phase III trial of adjuvant olaparib in patients with germline pathogenic variants in BRCA1/2 and high risk, early breast cancer.
Autoren Geyer CE, Garber JE, Gelber RD, Yothers G, Taboada M, Ross L, Rastogi P, Cui K, Arahmani A, Aktan G, Armstrong AC, Arnedos M, Balmaña J, Bergh J, Bliss J, Delaloge S, Domchek SM, Eisen A, Elsafy F, Fein LE, Fielding A, Ford JM, Friedman S, Gelmon KA, Gianni L, Gnant M, Hollingsworth SJ, Im SA, Jager A, Jóhannsson ÓÞ, Lakhani SR, Janni W, Linderholm B, Liu TW, Loman N, Korde L, Loibl S, Lucas PC, Marmé F, Martinez de Dueñas E, McConnell R, Phillips KA, Piccart M, Rossi G, Schmutzler R, Senkus E, Shao Z, Sharma P, Singer CF, Španić T, Stickeler E, Toi M, Traina TA, Viale G, Zoppoli G, Park YH, Yerushalmi R, Yang H, Pang D, Jung KH, Mailliez A, Fan Z, Tennevet I, Zhang J, Nagy T, Sonke GS, Sun Q, Parton M, Colleoni MA, Schmidt M, Brufsky AM, Razaq W, Kaufman B, Cameron D, Campbell C, Tutt ANJ
Erscheinungsdaten Annals of oncology : official journal of the European Society for Medical Oncology. 2022 Oct 10. pii: S0923-7534(22)04165-5. doi: 10.1016/j.annonc.2022.09.159
Publikations ID PMID: 36228963
 


tRNA 2'-O-methylation by a duo of TRM7/FTSJ1 proteins modulates small RNA silencing in Drosophila.
Autoren Angelova MT, Dimitrova DG, Da Silva B, Marchand V, Jacquier C, Achour C, Brazane M, Goyenvalle C, Bourguignon-Igel V, Shehzada S, Khouider S, Lence T, Guerineau V, Roignant JY, Antoniewski C, Teysset L, Bregeon D, Motorin Y, Schaefer MR, Carré C
Erscheinungsdaten Nucleic acids research. 2020 Jan 16. pii: 5707191. doi: 10.1093/nar/gkaa002
Publikations ID PMID: 31943105